{"id":"CHEMBL1076263","canonicalSmiles":"CS(=O)(=O)Nc1ccc2c(c1)S(=O)(=O)N=C(C1=C(O)[C@@H]3[C@H]4CC[C@H](C4)[C@@H]3N(Cc3ccc(F)cc3)C1=O)N2","inchiKey":"DEKOYVOWOVJMPM-RLHIPHHXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SETROBUVIR","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ANA-598","ANA598","RO-5466731","RO5466731","Setrobuvir"],"crossReferences":{"Wikipedia":["Setrobuvir"],"drugbank":["DB12051"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL109","canonicalSmiles":"CCCC(CCC)C(=O)O","inchiKey":"NIJJYAXOARWZEE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"VALPROIC ACID","yearOfFirstApproval":1978,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Convulex","Depakene","Depakote","Stavzor","Valproic acid"],"synonyms":["44089","NSC-93819","Valproic acid"],"crossReferences":{"DailyMed":["divalproex%20sodium","valproate%20sodium","valproic%20acid"],"PubChem":["144204642","144209161","144210920","170465446","17389523","26752921","399407","90341449"],"TG-GATEs":["5"],"Wikipedia":["Valproic_acid"],"drugbank":["DB00313"],"chEBI":["39867"]},"childChemblIds":["CHEMBL2315212","CHEMBL2105613","CHEMBL433"],"count":56,"approvedIndications":["EFO_1000877","EFO_0000474","EFO_0000289","Orphanet_64280","HP_0002121"],"linkedTargets":{"rows":["ENSG00000112294"],"count":1},"linkedDiseases":{"rows":["EFO_0008525","EFO_0004777","EFO_0001075","EFO_0000756","EFO_0000249","EFO_0003015","EFO_0003829","EFO_1001951","EFO_0000565","EFO_0000309","EFO_0000339","MONDO_0002974","MONDO_0008903","EFO_0000253","EFO_0000692","HP_0002121","EFO_0000198","EFO_0002618","EFO_0008526","EFO_0005762","EFO_1000877","EFO_0003888","EFO_0003821","MONDO_0008170","EFO_0000180","EFO_0003758","EFO_0002939","EFO_1001968","MONDO_0015643","MONDO_0021144","EFO_1001918","MONDO_0008315","Orphanet_783","Orphanet_791","EFO_0000546","MP_0001914","Orphanet_399","MONDO_0015917","EFO_0003841","EFO_0005800","EFO_0000270","EFO_0000574","HP_0031273","MONDO_0021640","EFO_0009878","MONDO_0037255","HP_0000726","MONDO_0007254","EFO_0004252","EFO_0009267","EFO_1001469","MONDO_0001187","EFO_0004247","EFO_0000474","EFO_0000289","MONDO_0002050","Orphanet_683","EFO_0009430","EFO_0000326","EFO_0003761","EFO_0002499","EFO_0007527","EFO_0000717","EFO_0005230","MONDO_0003478","EFO_1000158","EFO_0000616","EFO_0006859","HP_0010865","EFO_0000403","EFO_0000222","EFO_0009963","EFO_0001358","HP_0001250","Orphanet_64280","EFO_0001073","EFO_0003060","EFO_0000311","HP_0000713","Orphanet_368","Orphanet_83419","EFO_0000095","EFO_0000764","EFO_0000702","MONDO_0016093","EFO_0005611","MONDO_0043510","EFO_0005411","EFO_0000519","EFO_0000691","EFO_0004191","EFO_0000181"],"count":92},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1978 and has 5 approved and 51 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL113690","canonicalSmiles":"CCCCn1c(Cc2cc(OC)c(OC)c(OC)c2)nc2c(N)ncnc21","inchiKey":"TUOSCZDRWRYPRS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL113690","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02754"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1161633","canonicalSmiles":"[O-][Cl+2]([O-])O","inchiKey":"XTEGARKTQYYJKE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHLORATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Chlorate"],"crossReferences":{"drugbank":["DB14150"],"chEBI":["17322"]},"childChemblIds":["CHEMBL1559268","CHEMBL3188561"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1186610","canonicalSmiles":"CCCC(CCC)C(=O)O[C@@H]1C[C@@H]2CC[C@H](C1)[N+]2(C)C","inchiKey":"XGGHHHBGPSNXFE-ZSHCYNCHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ANISOTROPINE","yearOfFirstApproval":1962,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Anisotropine"],"crossReferences":{"PubChem":["50103910","50103911"],"Wikipedia":["Octatropine_methylbromide"]},"childChemblIds":["CHEMBL1578"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1962."}
{"id":"CHEMBL1200388","canonicalSmiles":"Cc1onc(-c2ccccc2Cl)c1C(=O)N[C@@H]1C(=O)N2[C@@H](C(=O)[O-])C(C)(C)S[C@H]12.O.[Na+]","inchiKey":"KCUWTKOTPIUBRI-VICXVTCVSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"CLOXACILLIN SODIUM","yearOfFirstApproval":1974,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL891","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cloxacillin sodium","Cloxapen","Dariclox","Ekvacillin","Orbenin","Tegopen"],"synonyms":["BRL-1621","Cloxacillin sodium","Cloxacillin sodium hydrate","Cloxacillin sodium salt monohydrate","P-25"],"crossReferences":{"PubChem":["57264344"],"chEBI":["34978"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1974 and has 2 investigational indications."}
{"id":"CHEMBL1200389","canonicalSmiles":"Brc1c(NC2=NCCN2)ccc2nccnc12.O=C(O)[C@H](O)[C@@H](O)C(=O)O","inchiKey":"QZHBYNSSDLTCRG-LREBCSMRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1200389","maximumClinicalTrialPhase":0,"parentId":"CHEMBL844","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1200532","canonicalSmiles":"CN1CCC(CN2c3ccccc3Sc3ccccc32)C1.Cl","inchiKey":"IEISBKIVLDXSMZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHDILAZINE HYDROCHLORIDE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1200959","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Methdilazine hydrochloride","Tacaryl"],"synonyms":["Methdilazine hydrochloride"],"crossReferences":{"PubChem":["144203598","562732"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1200659","canonicalSmiles":"CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)O.O=C(O)/C=C\\C(=O)O","inchiKey":"OYFJQPXVCSSHAI-QFPUQLAESA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"ENALAPRIL MALEATE","yearOfFirstApproval":1985,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL578","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ednyt","Enalapril maleate","Enapren","Epaned","Epaned kit","Innovace","Pralenal 10","Pralenal 2.5","Pralenal 20","Pralenal 5","Renitec","Vasotec","Xanef"],"synonyms":["Enalapril maleate","MK-421"],"crossReferences":{"DailyMed":["enalapril%20maleate"],"PubChem":["56424090","855584"],"chEBI":["4785"]},"count":5,"approvedIndications":["EFO_0000537"],"linkedTargets":{"rows":["ENSG00000159640"],"count":1},"linkedDiseases":{"rows":["EFO_0000685","HP_0000093","EFO_0005669","EFO_1002032","EFO_0000668","EFO_0000537"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1985 and is indicated for hypertension and has 4 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200693","drugType":"Small molecule","blackBoxWarning":false,"name":"MANGANESE CHLORIDE","yearOfFirstApproval":1986,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["CMC-001","CMC001","Manganese chloride","Manganese chloride tetrahydrate","NSC-9879"],"crossReferences":{"Wikipedia":["Manganese(II)_chloride"],"chEBI":["63041"]},"childChemblIds":["CHEMBL1200548"],"count":4,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1986 and has 4 investigational indications."}
{"id":"CHEMBL1200718","canonicalSmiles":"[Mg+2].[OH-].[OH-]","inchiKey":"VTHJTEIRLNZDEV-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"MAGNESIA, [MILK OF]","yearOfFirstApproval":2000,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cremaffin","Crm of magnesia","Hydro-Magna","Magnalax","Mil-par","Milk of magnesia","Mint-o-mag","Oxaine m","Phillips magnesia tablets","Phillips milk of magnesia","Phillips milk of magnesia liquid"],"synonyms":["E528","Magnesia magma","Magnesia, [milk of]","Magnesium hydroxide"],"crossReferences":{"DailyMed":["magnesium%20hydroxide"],"Wikipedia":["Magnesium_hydroxide"],"drugbank":["DB09104"],"chEBI":["6637"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2000."}
{"id":"CHEMBL1200736","canonicalSmiles":"O=C([O-])[O-].[Mg+2]","inchiKey":"ZLNQQNXFFQJAID-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"MAGNESIUM CARBONATE","yearOfFirstApproval":1990,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Andrews","Mag carb","Mag carb arom","Mag carb co","Magnesite"],"synonyms":["C.I. 77713","E504","Light magnesium carbonate","Magnesium carbonate","NSC-83511"],"crossReferences":{"DailyMed":["magnesium%20carbonate"],"DrugCentral":["4288"],"Wikipedia":["Magnesium_carbonate"],"drugbank":["DB09481"],"chEBI":["31793"]},"count":1,"approvedIndications":["HP_0002019"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1990 and is indicated for constipation."}
{"id":"CHEMBL1200796","canonicalSmiles":"O.O=P1(N(CCCl)CCCl)NCCCO1","inchiKey":"PWOQRKCAHTVFLB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CYCLOPHOSPHAMIDE","yearOfFirstApproval":1959,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL88","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cyclophosphamide","Cytoxan","Cytoxan (lyophilized)","Endoxana","Lyophilized cytoxan","Neosar"],"synonyms":["B-518","Cyclophosphamide","Cyclophosphamide anhydrous","Cyclophosphamide hydrate","Cyclophosphamide monohydrate","NSC-26271"],"crossReferences":{"DailyMed":["cyclophosphamide"],"PubChem":["144203651","144208701","144210847","170464624","17389078","26747956","50086596"],"chEBI":["4026"]},"count":220,"approvedIndications":["MONDO_0009348","EFO_0000616","EFO_0003869","MONDO_0007254","EFO_0000574","EFO_0001378","EFO_0000183","MONDO_0003659","EFO_0000305","EFO_0000311"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1959 and has 10 approved and 210 investigational indications."}
{"id":"CHEMBL1200825","canonicalSmiles":"CCC(=O)C(CC(C)N(C)C)(c1ccccc1)c1ccccc1.Cl","inchiKey":"FJQXCDYVZAHXNS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"METHADONE HYDROCHLORIDE","yearOfFirstApproval":1947,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL651","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dolophine hydrochloride","Eptadone","Martindale","Methadone hydrochloride","Methadone hydrochloride intensol","Methadose","Metharose","Methex","Physeptone","Pinadone","Synastone","Westadone"],"synonyms":["AN-148","Methadone hydrochloride","Methadone hydrochloride cii","Methadonium chloride","NSC-19600"],"crossReferences":{"DailyMed":["methadone%20hydrochloride"],"PubChem":["144206448","144209224","144210950"],"chEBI":["50140"]},"count":3,"approvedIndications":["EFO_0003843"],"linkedTargets":{"rows":["ENSG00000112038"],"count":1},"linkedDiseases":{"rows":["MONDO_0000726","EFO_0000764","HP_0008419","EFO_0003843"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1947 and is indicated for pain and has 2 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200861","canonicalSmiles":"O=C(O)[C@@H](O)[C@H](O)C(=O)O","inchiKey":"FEWJPZIEWOKRBE-LWMBPPNESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TARTARIC ACID","yearOfFirstApproval":1985,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["E334","Tartaric acid"],"crossReferences":{"PubChem":["4253871","49648471"],"Wikipedia":["Tartaric_acid"],"drugbank":["DB01694"],"chEBI":["15672"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1985."}
{"id":"CHEMBL1200909","canonicalSmiles":"CC(C)(C)CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C","inchiKey":"HUMXXHTVHHLNRO-KAJVQRHHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PREDNISOLONE TEBUTATE","yearOfFirstApproval":1956,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Hydeltra-tba","Prednisolone tebutate"],"synonyms":["Prednisolone butylacetate","Prednisolone tebutate"],"crossReferences":{"PubChem":["170465430"],"drugbank":["DB14632"],"chEBI":["8381"]},"count":3,"approvedIndications":["EFO_0009552","HP_0001742","EFO_0005752"],"linkedTargets":{"rows":["ENSG00000113580"],"count":1},"linkedDiseases":{"rows":["EFO_0009552","HP_0001742","EFO_0005752","HP_0004798"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1956 and has 3 approved indications."}
{"id":"CHEMBL1200916","canonicalSmiles":"CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2.Cl","inchiKey":"NZFNXWQNBYZDAQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"THIORIDAZINE HYDROCHLORIDE","yearOfFirstApproval":1962,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL479","hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United Kingdom"," Worldwide"],"classes":["Cardiotoxicity"],"year":2005},"tradeNames":["Mellaril","Thioridazine hydrochloride","Thioridazine hydrochloride intensol"],"synonyms":["Thioridazine hydrochloride"],"crossReferences":{"DailyMed":["thioridazine%20hydrochloride"],"PubChem":["144209999","26747699","26747700","50107199","50107200","50107201","56422406","855568"],"chEBI":["48566"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1962. It was withdrawn in United Kingdom and  Worldwide initially in 2005 due to Cardiotoxicity. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200936","canonicalSmiles":"CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O.CCN(CC)CCOC(=O)c1ccc(N)cc1.O","inchiKey":"KZDCMKVLEYCGQX-UDPGNSCCSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"PENICILLIN G PROCAINE","yearOfFirstApproval":1948,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1628385","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Crysticillin","Duracillin","Duracillin a.s.","Penicillin g procaine","Pfizerpen","Pfizerpen-as","Procaine Penicillin","Wycillin"],"synonyms":["Benzylpenicillin procaine","Penicillin g procaine","Procaine Benzylpenicillin","Procaine penicillin"],"crossReferences":{"DailyMed":["penicillin%20g%20procaine"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1948 and has 3 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201041","canonicalSmiles":"CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](NC(=O)N3CCNC3=O)c3ccccc3)C(=O)N2[C@H]1C(=O)[O-].[Na+]","inchiKey":"UVOCNBWUHNCKJM-XFAPPKAWSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"AZLOCILLIN SODIUM","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1537","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Azlin","Securopen"],"synonyms":["Azlocillin sodium"],"crossReferences":{"chEBI":["51864"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1201098","canonicalSmiles":"CO[C@@]1(NC(=O)C2SC(=C(C(N)=O)C(=O)[O-])S2)C(=O)N2C(C(=O)[O-])=C(CSc3nnnn3C)CS[C@@H]21.[Na+].[Na+]","inchiKey":"ZQQALMSFFARWPK-GLHLDKNHSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"CEFOTETAN DISODIUM","yearOfFirstApproval":1985,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL474579","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cefotan","Cefotetan","Yamatetan"],"synonyms":["Cefotetan disodium","Cefotetan disodium salt","Cefotetan sodium","YM-09330"],"crossReferences":{"DailyMed":["cefotetan%20disodium"],"chEBI":["34617"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1985 and has 1 investigational indication."}
{"id":"CHEMBL1201233","canonicalSmiles":"CCOC(=O)[C@@](C)(N)Cc1ccc(O)c(O)c1","inchiKey":"SVEBYYWCXTVYCR-LBPRGKRZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHYLDOPATE","yearOfFirstApproval":1962,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Methyldopate"],"childChemblIds":["CHEMBL1200432"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1962."}
{"id":"CHEMBL1201289","canonicalSmiles":"CCCCCCCCCCCCCCCC(=O)O[C@@H]1[C@@H](O)[C@@H](O)[C@@H]([C@H](NC(=O)[C@@H]2C[C@@H](CCC)CN2C)[C@H](C)Cl)O[C@@H]1SC","inchiKey":"OYSKUZDIHNKWLV-PRUAPSLNSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"CLINDAMYCIN PALMITATE","yearOfFirstApproval":1986,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Clindamycin palmitate"],"crossReferences":{"DailyMed":["clindamycin%20palmitate%20hydrochloride"]},"childChemblIds":["CHEMBL1200632"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1986. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201581","drugType":"Antibody","blackBoxWarning":true,"name":"INFLIXIMAB","yearOfFirstApproval":1998,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Inflectra","Remicade","Remsima"],"synonyms":["ABP 710","BOW015","Infliximab","NI-071","TA-650","cA2"],"crossReferences":{"DailyMed":["infliximab","infliximab-abda","infliximab-axxq","infliximab-dyyb"],"DrugCentral":["4974"],"Wikipedia":["Infliximab"]},"count":50,"approvedIndications":["EFO_0000729","EFO_0000685","EFO_0003898","EFO_0000676","EFO_0003778","EFO_0000540","EFO_0000384"],"linkedTargets":{"rows":["ENSG00000232810"],"count":1},"linkedDiseases":{"rows":["EFO_0000729","EFO_0004683","EFO_1000710","EFO_0003780","EFO_0000756","EFO_1000747","EFO_0000540","EFO_0002506","MONDO_0008903","EFO_0000783","EFO_0000676","EFO_0004616","HP_0003419","HP_0012378","EFO_0004276","EFO_0000692","Orphanet_379","EFO_1000749","EFO_0000198","MONDO_0013730","EFO_1001857","EFO_0002687","HP_0002039","EFO_0007168","EFO_0000384","EFO_1000784","EFO_0004232","EFO_1001209","EFO_1001231","EFO_0007460","MONDO_0019474","MONDO_0100096","MONDO_0003937","EFO_0000398","EFO_0001359","HP_0004326","EFO_0000341","EFO_0003767","EFO_0001065","EFO_0003778","EFO_0004246","MONDO_0001718","EFO_0008518","EFO_0000289","MONDO_0002050","EFO_0003047","EFO_0009321","EFO_0007527","Orphanet_797","EFO_0000685","EFO_0003898","EFO_0004599","EFO_0002609","EFO_0000537","EFO_0004220","EFO_0005297","EFO_0000706","EFO_0004775","EFO_0003872"],"count":59},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1998 and has 7 approved and 43 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1212979","canonicalSmiles":"Nc1ncnc2c1ncn2[C@@H]1O[C@H](CF)[C@@H](O)[C@H]1O","inchiKey":"QPVLKMICBYRPSX-KQYNXXCUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1212979","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03716"],"chEBI":["12060"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1229214","canonicalSmiles":"CC[N+]1(CC)CCC(=C(c2ccccc2)c2ccccc2)C1C","inchiKey":"ZYEPZINLLPPBMI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PRIFINIUM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB13254"]},"childChemblIds":["CHEMBL1213353"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1232461","canonicalSmiles":"CCNC(=O)C[C@@H]1N=C(c2ccc(Cl)cc2)c2cc(OC)ccc2-n2c(C)nnc21","inchiKey":"AAAQFGUYHFJNHI-SFHVURJKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MOLIBRESIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GSK-525762","GSK-525762A","GSK525762","GSK525762A","I-BET 762","Molibresib"],"childChemblIds":["CHEMBL4297217"],"count":2,"linkedTargets":{"rows":["ENSG00000169925","ENSG00000204256","ENSG00000137948","ENSG00000141867"],"count":4},"linkedDiseases":{"rows":["EFO_0000616","EFO_0000313"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1232903","canonicalSmiles":"O=P(O)(O)OC(CO)CO","inchiKey":"DHCLVCXQIBBOPH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GLYCERYLPHOSPHATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["29217795"],"drugbank":["DB01779"],"chEBI":["17270"]},"childChemblIds":["CHEMBL3707206"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1234490","canonicalSmiles":"CCNc1nc(NC(C)(C)C)nc(SC)n1","inchiKey":"IROINLKCQGIITA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TERBUTRYNE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144209280","144213458","26757718","47193751"],"drugbank":["DB08215"],"chEBI":["44156"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1235346","canonicalSmiles":"O=C(O)c1cc(C(=O)O)c(C(=O)O)cc1C(=O)O","inchiKey":"CYIDZMCFTVVTJO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PYROMELLITIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["1,2,4,5-Benzenetetracarboxylic Acid"],"crossReferences":{"PubChem":["144212347"],"drugbank":["DB02749"],"chEBI":["45165"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1236936","canonicalSmiles":"O=C(O)CCCCN(CCc1ccccc1OCc1ccc(CCc2ccccc2)cc1)Cc1ccc(C(=O)O)cc1","inchiKey":"WPYWMXNXEZFMAK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CINACIGUAT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BAY 58-2667","Cinaciguat"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1243","canonicalSmiles":"Nc1ccc(S(=O)(=O)NC(=O)c2ccccc2)cc1","inchiKey":"PBCZLFBEBARBBI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SULFABENZAMIDE","yearOfFirstApproval":1945,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Sulfabenzamide","Sulfabenzamide (triple sulfa)"],"crossReferences":{"PubChem":["11112278","144203961","170465133","26746972","855720"],"Wikipedia":["Sulfabenzamide"],"drugbank":["DB09355"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1945."}
{"id":"CHEMBL1259059","canonicalSmiles":"CC(C)OC(=O)[C@H](C)N[P@](=O)(OC[C@H]1O[C@@H](n2ccc(=O)[nH]c2=O)[C@](C)(F)[C@@H]1O)Oc1ccccc1","inchiKey":"TTZHDVOVKQGIBA-IQWMDFIBSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"SOFOSBUVIR","yearOfFirstApproval":2013,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Psi-7977, gs-7977","Sovaldi"],"synonyms":["GS-7977","GS7977","PSI-7977","Sofosbuvir"],"crossReferences":{"DailyMed":["sofosbuvir"],"drugbank":["DB08934"],"chEBI":["85083"]},"count":6,"approvedIndications":["EFO_0004220","EFO_0003047","EFO_0000763"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2013 and has 3 approved and 3 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1337960","canonicalSmiles":"Cl.Nc1c2c(nc3ccccc13)CCCC2.O","inchiKey":"PXGRMZYJAOQPNZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"[14C]-Tacrine Monohydrate Monohydrochloride","maximumClinicalTrialPhase":0,"parentId":"CHEMBL95","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["[14C]-Tacrine Monohydrate Monohydrochloride"],"crossReferences":{"PubChem":["11112951","56424070"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL135","canonicalSmiles":"C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1CC[C@@H]2O","inchiKey":"VOXZDWNPVJITMN-ZBRFXRBCSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"ESTRADIOL","yearOfFirstApproval":1975,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Adgyn estro","Alora","Aquagen","Bedol","Climara","Climara Pro","Dermestril 100","Dermestril 25","Dermestril 50","Dermestril septem 25","Dermestril septem 50","Dermestril septem 75","Divigel","E-Cypionate","Elestrim","Elestrin","Elleste solo","Elleste solo mx 40","Elleste solo mx 80","Esclim","Estrace","Estraderm","Estraderm mx 100","Estraderm mx 25","Estraderm mx 50","Estraderm mx 75","Estraderm tts 100","Estraderm tts 25","Estraderm tts 50","Estradiol","Estrasorb","Estring","Estrogel","Evamist","Evorel 100","Evorel 25","Evorel 50","Evorel 75","Fematrix 40","Fematrix 80","Fempatch","Femseven 100","Femseven 50","Femseven 75","Gvnodiol","Gynodiol","Gynogen","Imvexxy","Innofem","Menorest 37.5","Menorest 50","Menorest 75","Menoring 50","Menostar","Minivelle","Oestradiol","Progynova ts","Sandrena","Vagifem","Vagifem 18","Vagifem 8","Vivelle","Vivelle-dot","Zumenon"],"synonyms":["Agofollin","Alfatradiol","Depo-Estradiol","Destradiol","Dihydrotheelin","Dihydroxyestrin","Estradiol","Estradiol hemihydrate","Estrasorb","Gynergon","Gynoestryl","NSC-20293","NSC-9895","Oestradiol","WC-3011","WC3011"],"crossReferences":{"DailyMed":["estradiol"],"PubChem":["144204699","144209255","144210608","17389898","26753050","26753051","26753052","29215115","29215116","29215117","50105619","50105620","50124031","56422158","8139865","90341590"],"Wikipedia":["Estradiol"],"drugbank":["DB00783"],"chEBI":["16469"]},"count":46,"approvedIndications":["MONDO_0002146","HP_0008209","HP_0030016"],"linkedTargets":{"rows":["ENSG00000091831"],"count":1},"linkedDiseases":{"rows":["EFO_0003869","EFO_0000249","HP_0031217","EFO_1001271","HP_0000938","EFO_0003914","EFO_0003103","EFO_0004714","HP_0008209","EFO_0010270","EFO_0000692","Orphanet_145","EFO_1000906","EFO_0003821","EFO_0000180","EFO_0009867","HP_0030016","EFO_0000660","EFO_0001663","MONDO_0008315","GO_0007568","MONDO_0100096","EFO_0000731","EFO_0001359","HP_0100607","Orphanet_881","EFO_1000859","EFO_0001360","EFO_0003922","EFO_0004320","EFO_0005204","MONDO_0001410","EFO_0001065","EFO_0007453","EFO_0009006","MONDO_0007254","HP_0000132","EFO_0003882","EFO_0000305","EFO_0002950","MONDO_0002146","MONDO_0041161","MONDO_0002050","HP_0002907","EFO_1001375","EFO_1000645","EFO_1000096","EFO_0004215","EFO_0000545","EFO_1001757","EFO_0009315","EFO_0000319","EFO_0001358","EFO_0004243","EFO_0001073","EFO_0003843","EFO_0000537","EFO_0003885","EFO_0010269","EFO_0009851","EFO_0000764","EFO_1000766","EFO_0005411","EFO_0004710"],"count":64},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1975 and has 3 approved and 43 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1363","canonicalSmiles":"COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1","inchiKey":"BPZSYCZIITTYBL-YJYMSZOUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ARFORMOTEROL","yearOfFirstApproval":2006,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Arformoterol","Formoterol r,r-form"],"crossReferences":{"DailyMed":["arformoterol%20tartrate"],"Wikipedia":["Formoterol"],"drugbank":["DB01274"],"chEBI":["408174"]},"childChemblIds":["CHEMBL3184383","CHEMBL605993","CHEMBL1200811","CHEMBL1951071"],"count":5,"linkedTargets":{"rows":["ENSG00000169252"],"count":1},"linkedDiseases":{"rows":["EFO_0000270","EFO_0000464","EFO_0006505","EFO_0009661","EFO_0000341","HP_0025428"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2006 and has 5 investigational indications."}
{"id":"CHEMBL139020","canonicalSmiles":"O=C(O)Cc1cccc([N+](=O)[O-])c1","inchiKey":"WUKHOVCMWXMOOA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL139020","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08193"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1420319","canonicalSmiles":"CC(C)(C)c1ccc(Oc2ccc(N)cn2)cc1","inchiKey":"WHIWGRCYMQLLAO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CB-103","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CB-103","Cb-103"],"crossReferences":{"PubChem":["26730448"],"drugbank":["DB15279"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1421383","canonicalSmiles":"C[C@H](CCC(=O)[O-])[C@H]1CC[C@H]2[C@H]3[C@H](C[C@H](O)[C@@]21C)[C@@]1(C)CC[C@@H](O)C[C@H]1C[C@H]3O.[Na+]","inchiKey":"NRHMKIHPTBHXPF-TUJRSCDTSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1421383","maximumClinicalTrialPhase":0,"parentId":"CHEMBL205596","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144209733","17388734","50085970"],"chEBI":["26711"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1439973","canonicalSmiles":"CC(C)(O)C(Cl)(Cl)Cl","inchiKey":"OSASVXMJTNOKOY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHLOROBUTANOL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Chloretone"],"synonyms":["Chlorbutol","Chlorobutanol","NSC-44794","Trichlorisobutylalcohol"],"crossReferences":{"PubChem":["144205182","170465458","29215323","29215324"],"drugbank":["DB11386"]},"count":1,"approvedIndications":["HP_0002018"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for nausea."}
{"id":"CHEMBL1441059","canonicalSmiles":"CC(C)(C)NCC(O)c1ccc(O)c(CO)c1.CC(C)(C)NCC(O)c1ccc(O)c(CO)c1.O=S(=O)(O)O","inchiKey":"BNPSSFBOAGDEEL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"ALBUTEROL SULFATE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL714","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Accuneb","Albuterol sulfate","Proair","Proair digihaler","Proair hfa","Proair respiclick","Proventil","Proventil-hfa","Ventolin","Ventolin hfa","Ventolin rotacaps","Volmax","Vospire er"],"synonyms":["Albuterol sulfate","NSC-289928","R03AC02","R03CC02","SCH 13949W SULFATE","SCH-13949W SULFATE","Salbutamol sulfate"],"crossReferences":{"DailyMed":["albuterol%20sulfate"],"PubChem":["50107002"]},"count":6,"approvedIndications":["EFO_0000270","EFO_0000341","HP_0025428"],"linkedTargets":{"rows":["ENSG00000169252"],"count":1},"linkedDiseases":{"rows":["MONDO_0100130","EFO_0000270","EFO_0010638","EFO_0000341","EFO_0000319","HP_0025428","EFO_0003818","MONDO_0004784"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1982 and has 3 approved and 3 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL146506","canonicalSmiles":"C/C(=C\\c1ccc(OCCN2CCOCC2)cc1)c1ccc2c(c1)C(C)(C)CCC2(C)C","inchiKey":"OUQPTBCOEKUHBH-LSDHQDQOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MOFAROTENE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mofarotene","Ro-408757"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL14687","canonicalSmiles":"CCCO","inchiKey":"BDERNNFJNOPAEC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PROPANOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ethylcarbinol","Propan-1-ol","Propanol"],"crossReferences":{"Wikipedia":["1-Propanol"],"drugbank":["DB03175"],"chEBI":["28831"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL14762","canonicalSmiles":"CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1","inchiKey":"BTIHMVBBUGXLCJ-OAHLLOKOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SELICICLIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AL-39256","CYC-202","Cyc-202","NSC-701554","Seliciclib"],"crossReferences":{"PubChem":["124891685","26753649","26753650","50100113","50107006","527377"],"Wikipedia":["Seliciclib"],"drugbank":["DB06195"],"chEBI":["45307"]},"count":5,"linkedTargets":{"rows":["ENSG00000123374","ENSG00000164885","ENSG00000134058","ENSG00000136807","ENSG00000170312"],"count":5},"linkedDiseases":{"rows":["EFO_0000616","MONDO_0007254","Orphanet_586","EFO_1001110","EFO_0003060"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL1496","canonicalSmiles":"CC(C)c1nc(N(C)S(C)(=O)=O)nc(-c2ccc(F)cc2)c1/C=C/[C@@H](O)C[C@@H](O)CC(=O)O","inchiKey":"BPRHUIZQVSMCRT-VEUZHWNKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ROSUVASTATIN","yearOfFirstApproval":2003,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Rosuvastatin","ZD-4522","ZD4522"],"crossReferences":{"DailyMed":["rosuvastatin%20calcium"],"Wikipedia":["Rosuvastatin"],"drugbank":["DB01098"],"chEBI":["38545"]},"childChemblIds":["CHEMBL1744447"],"count":68,"approvedIndications":["EFO_0000319"],"linkedTargets":{"rows":["ENSG00000113161"],"count":1},"linkedDiseases":{"rows":["MONDO_0001583","EFO_0009505","EFO_0000275","EFO_1000657","EFO_0005669","EFO_0003774","EFO_0000266","EFO_0000540","HP_0100545","EFO_1001951","EFO_0003913","EFO_0003964","EFO_0003914","EFO_0004714","EFO_0008585","EFO_0002690","EFO_1000807","Orphanet_391665","EFO_0000400","EFO_0000407","HP_0003124","EFO_0002687","HP_0001685","EFO_0002508","MONDO_0008170","EFO_0000180","EFO_0004286","EFO_1001512","EFO_0000701","EFO_0009516","EFO_0000384","Orphanet_95","MONDO_0008315","Orphanet_309005","HP_0100806","EFO_0009426","MONDO_0100096","Orphanet_412","EFO_1000049","EFO_0000270","EFO_0001359","EFO_0003907","EFO_0000341","EFO_0001360","MONDO_0001641","EFO_0000668","EFO_0005672","EFO_0003086","EFO_1001454","MONDO_0007254","EFO_1001249","EFO_1001413","EFO_0000373","EFO_1001461","EFO_1002048","Orphanet_91378","EFO_0004211","HP_0000083","MONDO_0041161","MONDO_0002050","EFO_0005226","EFO_0003144","EFO_0000712","EFO_0000673","EFO_0004272","EFO_0004826","EFO_0003047","EFO_0000717","EFO_0002617","EFO_0000616","EFO_0000685","HP_0002140","EFO_0001645","EFO_0009783","EFO_0000556","EFO_0000319","EFO_0001073","EFO_0004911","EFO_0003060","EFO_0000537","EFO_0000311","EFO_0000195","EFO_0000589","EFO_1001150","EFO_0001068","MONDO_0021661","EFO_0000649","EFO_0000764","Orphanet_79211","EFO_0008583","EFO_0000612","EFO_0003918"],"count":92},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2003 and is indicated for cardiovascular disease and has 67 investigational indications."}
{"id":"CHEMBL150261","canonicalSmiles":"N[C@H]1CC[C@H](Nc2nc(NCc3ccccc3)c3ncn(C4CCCC4)c3n2)CC1","inchiKey":"JTVILUUAQWQWBK-IYARVYRRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL150261","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04288"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1512677","canonicalSmiles":"CCCCCc1ccc(C)cc1O","inchiKey":"CKGWFZQGEQJZIL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMYLMETACRESOL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Throaties"],"synonyms":["Amylmetacresol"],"crossReferences":{"PubChem":["144206204","50125738"],"drugbank":["DB13908"],"chEBI":["48213"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL1589793","canonicalSmiles":"CCN(CC)c1ccc(C(=C2C=CC(=[N+](CC)CC)C=C2)c2ccccc2)cc1","inchiKey":"HXCILVUBKWANLN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1589793","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["29217881"],"drugbank":["DB11279"],"chEBI":["88176"]},"childChemblIds":["CHEMBL1790039"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1677","canonicalSmiles":"Cl.Nc1c2c(nc3ccccc13)CCCC2","inchiKey":"ZUFVXZVXEJHHBN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TACRINE HYDROCHLORIDE","yearOfFirstApproval":1993,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL95","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Alzyme","Cognex"],"synonyms":["CI-970","Tacrine hydrochloride"],"crossReferences":{"PubChem":["11532943","144207497","17388697","26747422","49732004","50105756"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1993."}
{"id":"CHEMBL1733174","canonicalSmiles":"CCOc1cc(N)c(Cl)cc1C(=O)NCC1CN(Cc2ccc(F)cc2)CCO1.O=C(O)CC(O)(CC(=O)O)C(=O)O","inchiKey":"HUZTYZBFZKRPFG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MOSAPRIDE CITRATE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL60889","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AS-4370","Gasmotin","Mosapride citrate"],"crossReferences":{"PubChem":["144205427","170466008","49681606"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL1738757","canonicalSmiles":"CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc4ncccc4c3)c(F)c2)ccn1","inchiKey":"WVXNSAVVKYZVOE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"REBASTINIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Dp-1919"],"synonyms":["DCC-2036","DCC-2036 FREE BASE","DP-1919","Dcc-2036","Rebastinib"],"crossReferences":{"PubChem":["137276016"],"drugbank":["DB13005"],"chEBI":["62166"]},"childChemblIds":["CHEMBL2107833"],"count":2,"linkedTargets":{"rows":["ENSG00000097007"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0000304","EFO_0000339"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1743028","drugType":"Antibody","blackBoxWarning":false,"name":"GLEMBATUMUMAB VEDOTIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CDX-011","CR-011-VCMMAE","Glembatumumab vedotin"],"count":4,"linkedTargets":{"rows":["ENSG00000136235"],"count":1},"linkedDiseases":{"rows":["EFO_1000616","EFO_0000637","EFO_0000756","MONDO_0007254","EFO_0000708"],"count":5},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL176072","canonicalSmiles":"CN(C)c1cccc2c(S(=O)(=O)N[C@@H](Cc3ccc(OS(=O)(=O)c4cccc5c(N(C)C)cccc45)cc3)C(=O)O)cccc12","inchiKey":"LUBOPDUYHWABFG-NDEPHWFRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL176072","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03157"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL178938","canonicalSmiles":"CNCc1ccc(-c2cccnc2)o1","inchiKey":"MDGMPFRIYUFRRX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL178938","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07617"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1900403","canonicalSmiles":"C1CCN2C[C@H]3C[C@H](CN4CCCC[C@H]34)[C@@H]2C1.O.O=S(=O)(O)O","inchiKey":"SVHRKOXNUMMKNA-NFFOJHPUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1900403","maximumClinicalTrialPhase":0,"parentId":"CHEMBL412873","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["93576768"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1902981","canonicalSmiles":"CCc1ccc(C(=O)C(C)CN2CCCCC2)cc1","inchiKey":"SQUNAWUMZGQQJD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EPERISONE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Eperisone","Eperisone hydrochloride"],"crossReferences":{"PubChem":["50113017"],"Wikipedia":["Eperisone"],"drugbank":["DB08992"],"chEBI":["77070"]},"childChemblIds":["CHEMBL2360601"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL194009","canonicalSmiles":"Nc1ncccc1OCc1ccccc1","inchiKey":"NMCBWICNRJLKKM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL194009","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02352"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1974188","canonicalSmiles":"COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12.O.O","inchiKey":"VVZOMPVNGWNDOE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1974188","maximumClinicalTrialPhase":0,"parentId":"CHEMBL31","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["121269834"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL198877","canonicalSmiles":"Oc1ccc([C@H]2COc3cc(O)ccc3C2)cc1","inchiKey":"ADFCQWZHKCXPAJ-GFCCVEGCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AUS-131","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(S)-Equol","Aus-131"],"crossReferences":{"Wikipedia":["Equol"],"drugbank":["DB11674"],"chEBI":["34741"]},"count":4,"linkedTargets":{"rows":["ENSG00000140009"],"count":1},"linkedDiseases":{"rows":["EFO_0000249","MONDO_0007254","EFO_0000284","EFO_0003922"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL2023895","canonicalSmiles":"N=C(N)c1ccc(/C=C/c2ccc(C(=N)N)cc2O)cc1.O=S(=O)(O)CCO.O=S(=O)(O)CCO","inchiKey":"XVTQTNAKZYLTNZ-HFPMQDOPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HYDROXYSTILBAMIDINE ISETHIONATE","yearOfFirstApproval":1953,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1301","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Hydroxystilbamidine isethionate"],"synonyms":["Hydroxystilbamidine isethionate","NSC-259242","Oxistilbamidine isethionate"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1953."}
{"id":"CHEMBL204394","canonicalSmiles":"Oc1ccc2c(O)cccc2c1","inchiKey":"FZZQNEVOYIYFPF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"Naphthalene-1,6-Diol","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Naphthalene-1,6-Diol"],"crossReferences":{"drugbank":["DB07661"],"chEBI":["42040"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2048410","canonicalSmiles":"CS(=O)(=O)c1cccc(C[C@H](N[14C](=O)c2c(Cl)cc3c(c2Cl)CCN(C(=O)c2ccc4ccoc4c2)C3)C(=O)O)c1","inchiKey":"JFOZKMSJYSPYLN-TZFMMTKISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL2048410","maximumClinicalTrialPhase":0,"parentId":"CHEMBL2048028","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2068237","drugType":"Small molecule","blackBoxWarning":true,"name":"CISPLATIN","yearOfFirstApproval":1978,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144204562","144207019","144209698","170464726"],"TG-GATEs":["132"]},"childChemblIds":["CHEMBL11359"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1978. This drug has a black box warning from the FDA."}
{"id":"CHEMBL2104445","canonicalSmiles":"CCOc1c(N)c2c(c(OCC)c1OCC)C(C1c3c(cc4c(c3OC)OCO4)CCN1C)OC2=O","inchiKey":"IRGJVQIJENCTQF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRITOQUALINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Hypostamine"],"synonyms":["L-554","Tritoqualine"],"crossReferences":{"drugbank":["DB13711"]},"count":1,"approvedIndications":["EFO_0003785"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for allergy."}
{"id":"CHEMBL2104462","canonicalSmiles":"COc1ccc2c(=O)c3ccccc3oc2c1CN1CCCCC1","inchiKey":"PYSOHOOUXFWCFF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MEPIXANOX","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mepixanox"],"crossReferences":{"drugbank":["DB13579"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2104786","canonicalSmiles":"CC(C)(CO)[C@@H](O)C(=O)NCCC(=O)NCCSSCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)CO","inchiKey":"DJWYOLJPSHDSAL-ROUUACIJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PANTETHINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pantethine"],"crossReferences":{"drugbank":["DB11190"],"chEBI":["31959"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2104962","canonicalSmiles":"Cc1ccc(S(=O)(=O)O)cc1.N#C[C@@H]1C[C@H](F)CN1C(=O)[C@@H](N)C(c1ccc(F)cc1)c1ccc(F)cc1","inchiKey":"MSCWUTTUQLYJFT-QMBKNIKNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DENAGLIPTIN TOSYLATE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL2110666","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Denagliptin tosylate","GW-823093C","GW823093C"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2104970","canonicalSmiles":"NC(=O)C1=C(O)C[C@@H]2C[C@@H]3Cc4cccc(O)c4C(=O)C3=C(O)[C@]2(O)C1=O","inchiKey":"ZXFCRFYULUUSDW-OWXODZSWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"INCYCLINIDE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Metastat"],"synonyms":["COL-3","Incyclinide","NSC-683551"],"crossReferences":{"drugbank":["DB11647"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2105340","canonicalSmiles":"Cc1cc(/C=C/c2ccc3cc(N(C)C)ccc3[n+]2C)c(C)n1-c1ccccc1.[Cl-]","inchiKey":"IKUGNXPCGVYRHO-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"PYRVINIUM CHLORIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1201303","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pyrvinium chloride"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2105359","canonicalSmiles":"C=C1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO","inchiKey":"WSVOMANDJDYYEY-CWNVBEKCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PREDNYLIDENE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Methylenprednisolone","Prednylidene"],"crossReferences":{"drugbank":["DB13208"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2105659","canonicalSmiles":"CCc1c(C(=O)C(N)=O)c2c(OCC(=O)OC)cccc2n1Cc1ccccc1","inchiKey":"VJYDOJXJUCJUHL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VARESPLADIB METHYL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["A-002","LY-333013","LY333013","S-3013","Varespladib methyl","Varespladib methyl ester"],"crossReferences":{"drugbank":["DB05737"]},"count":2,"linkedTargets":{"rows":["ENSG00000069764","ENSG00000188257","ENSG00000127472"],"count":3},"linkedDiseases":{"rows":["EFO_0003086","EFO_0001645","EFO_0005672"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2105716","canonicalSmiles":"O=C([O-])CSc1nnc(Br)n1-c1ccc(C2CC2)c2ccccc12.[Na+]","inchiKey":"FVYMVLTWIBGEMC-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"LESINURAD SODIUM","maximumClinicalTrialPhase":0,"parentId":"CHEMBL2105720","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Lesinurad sodium","RDEA594 SODIUM"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2105736","canonicalSmiles":"CC[C@H](C)[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N1CCOCC1)c1ccc(C)nc1C.O=S(=O)(O)c1ccccc1","inchiKey":"BEWUOCYETMDWGE-FKDQZALLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EPELSIBAN BESYLATE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL2037511","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Epelsiban besylate","GSK-557296B","GSK557296B"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2105758","canonicalSmiles":"O=C(Nc1nc(-c2cc(Cl)cs2)c(N2CCN(C3CCCCC3)CC2)s1)c1cnc(N2CCC(C(=O)O)CC2)c(Cl)c1.O=C(O)/C=C\\C(=O)O","inchiKey":"MISPBGHDNZYFNM-BTJKTKAUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AVATROMBOPAG MALEATE","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL2103883","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Doptelet"],"synonyms":["Avatrombopag maleate","E-5501 MALEATE","E5501 MALEATE"],"crossReferences":{"DailyMed":["avatrombopag%20maleate"]},"count":1,"approvedIndications":["HP_0001873"],"linkedTargets":{"rows":["ENSG00000117400"],"count":1},"linkedDiseases":{"rows":["HP_0001873"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2018 and is indicated for thrombocytopenia."}
{"id":"CHEMBL2105784","canonicalSmiles":"O=C(O)c1cc2ccccc2c(Cc2c(O)c(C(=O)O)cc3ccccc23)c1O.OC(CCCN1CCCCC1)(c1ccccc1)c1ccccc1","inchiKey":"WVPDEFZZHNQFFX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIPHENIDOL PAMOATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL936","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Diphenidol pamoate","SK&F 478-J"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2105834","canonicalSmiles":"C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)[C@H](N)Cc2ccccc2)CSSC[C@@H](C(=O)N[C@H](CO)[C@@H](C)O)NC1=O.O=C(O)c1cc2ccccc2c(Cc2c(O)c(C(=O)O)cc3ccccc23)c1O","inchiKey":"KFWJVABDRRDUHY-XJQYZYIXSA-N","drugType":"Protein","blackBoxWarning":false,"name":"OCTREOTIDE PAMOATE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL1680","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Octreotide embonate","Octreotide pamoate","SMS 201-995 PA","SMS PA","SMS-201-995 PA","SMS-PA"],"count":1,"description":"Protein drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2106399","canonicalSmiles":"CO[C@@H]1[C@@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@@H](OC(=O)CC(C)C)[C@H](C)O3)[C@H](N(C)C)[C@H]2O)[C@@H](CC=O)C[C@@H](C)[C@@H](O)/C=C/C=C/C[C@@H](C)OC(=O)C[C@H]1O","inchiKey":"IEMDOFXTVAPVLX-YWQHLDGFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"KITASAMYCIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Acetylkitasamycin","Kitasamycin","Kitasamycin tartrate"],"crossReferences":{"drugbank":["DB09309"],"chEBI":["34812"]},"childChemblIds":["CHEMBL2355304"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2106618","canonicalSmiles":"Cc1cc(C(=O)NCCc2ccc(S(=O)(=O)NC(=O)NN3CCCCCC3)cc2)no1","inchiKey":"ZKUDBRCEOBOWLF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GLISOXEPIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BAY B 4231","FBB 4231","Glisoxepide","RP 22410"],"crossReferences":{"PubChem":["144205252"],"drugbank":["DB01289"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2107369","canonicalSmiles":"CC(=O)O.CC(=O)O.CC(C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@H](C)N)C(N)=O","inchiKey":"FZVMMANVVHMVBM-OIXLVLAFSA-N","drugType":"Protein","blackBoxWarning":false,"name":"RUSALATIDE ACETATE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL2111105","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Chrysalin"],"synonyms":["Rusalatide acetate","Rusalatide acetate (3:2)","TP 508","TP-508 ACETATE","TRAP-508","TRAP-508 ACETATE"],"count":1,"description":"Protein drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2107870","drugType":"Oligonucleotide","blackBoxWarning":false,"name":"PEGNIVACOGIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pegnivacogin","RB-006","RB006","REG-1","REG1"],"count":1,"linkedTargets":{"rows":["ENSG00000101981"],"count":1},"linkedDiseases":{"rows":["EFO_0001645","EFO_0005672"],"count":2},"description":"Oligonucleotide drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2108431","drugType":"Antibody","blackBoxWarning":false,"name":"METELIMUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CAT-192","Metelimumab"],"description":"Antibody drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2108474","drugType":"Antibody","blackBoxWarning":false,"name":"MASLIMOMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Maslimomab"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2108512","drugType":"Unknown","blackBoxWarning":false,"name":"HEPATITIS B IMMUNE GLOBULIN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bayhep b","H-big","Hep-b-gammagee","Liberim hb"],"synonyms":["Hepatitis b immune globulin","Hepatitis b immunoglobulin"],"count":2,"description":"Unknown drug with a maximum clinical trial phase of IV (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2108611","drugType":"Antibody","blackBoxWarning":true,"name":"INOTUZUMAB OZOGAMICIN","yearOfFirstApproval":2017,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Besponsa"],"synonyms":["CMC-544","Inotuzumab ozogamicin","PF-05208773","WAY-207294","WAY-207294 CMC-544"],"crossReferences":{"DailyMed":["inotuzumab%20ozogamicin"]},"count":10,"approvedIndications":["EFO_0000616","EFO_0000094"],"linkedTargets":{"rows":["ENSG00000012124"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","MONDO_0000873","EFO_0000096","EFO_0000220","EFO_0000403","EFO_0000574","EFO_1000131","MONDO_0018906","EFO_0005952","EFO_0000094","MONDO_0044881","MONDO_0003541"],"count":12},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2017 and is indicated for neoplasm and b-cell acute lymphoblastic leukemia and has 8 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL2108679","drugType":"Antibody","blackBoxWarning":false,"name":"OZANEZUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Gsk1223249"],"synonyms":["GSK-1223249","GSK1223249","Ozanezumab"],"count":3,"linkedTargets":{"rows":["ENSG00000115310"],"count":1},"linkedDiseases":{"rows":["EFO_0003885","EFO_0003929","EFO_0000253"],"count":3},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2108710","drugType":"Unknown","blackBoxWarning":false,"name":"RIMABOTULINUMTOXINB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Myobloc"],"synonyms":["AN-0772","AN0772","BTX-8","BTX-B","Botulin b","Botulinum toxin type b","Rimabotulinumtoxinb"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2109198","drugType":"Unknown","blackBoxWarning":false,"name":"METHYLCELLULOSE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Celevac","Cellucon","Citrucel","Cologel","Methocel a","Nilstim"],"synonyms":["E-461","FEMA NO. 2696","INS NO.461","INS-461","Methycellulose","Methylcellulose"],"count":2,"approvedIndications":["HP_0002019"],"description":"Unknown drug with a maximum clinical trial phase of IV (across all indications) and is indicated for constipation and has 1 investigational indication."}
{"id":"CHEMBL2109279","drugType":"Antibody","blackBoxWarning":false,"name":"RG-7598","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DFRF4539A","RG-7598"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2109351","drugType":"Antibody","blackBoxWarning":false,"name":"FBT-A05","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["FBT-A05"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2109372","drugType":"Antibody","blackBoxWarning":false,"name":"MEDI-565","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MEDI-565","Medi-565"],"count":1,"linkedTargets":{"rows":["ENSG00000105388","ENSG00000198851"],"count":2},"linkedDiseases":{"rows":["EFO_0000228"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2109430","drugType":"Antibody","blackBoxWarning":false,"name":"GIMSILUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Gimsilumab","MORAb-022"],"count":2,"linkedTargets":{"rows":["ENSG00000164400"],"count":1},"linkedDiseases":{"rows":["EFO_0000685","MONDO_0100096"],"count":2},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2111108","canonicalSmiles":"N=C(N)c1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)n1","inchiKey":"NHKZSTHOYNWEEZ-AFCXAGJDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TARIBAVIRIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Taribavirin"],"crossReferences":{"drugbank":["DB06408"]},"childChemblIds":["CHEMBL2107375"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2159122","canonicalSmiles":"COc1ccc(CN(C(=O)[C@@H](N)Cc2c(C)cc(C(N)=O)cc2C)[C@@H](C)c2nc(-c3ccccc3)c[nH]2)cc1C(=O)O","inchiKey":"QFNHIDANIVGXPE-FNZWTVRRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ELUXADOLINE","yearOfFirstApproval":2015,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Truberzi","Viberzi"],"synonyms":["Eluxadoline","JNJ-27018966"],"crossReferences":{"DailyMed":["eluxadoline"],"drugbank":["DB09272"],"chEBI":["85980"]},"count":1,"approvedIndications":["EFO_0000555"],"linkedTargets":{"rows":["ENSG00000112038"],"count":1},"linkedDiseases":{"rows":["EFO_0000555","HP_0004798"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2015 and is indicated for irritable bowel syndrome."}
{"id":"CHEMBL216973","canonicalSmiles":"Nc1cccc2cnccc12","inchiKey":"DTVYNUOOZIKEEX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"5-Aminoisoquinoline","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["5-Aminoisoquinoline"],"crossReferences":{"PubChem":["4248661"],"drugbank":["DB04605"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2180605","canonicalSmiles":"CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12.Cl","inchiKey":"QHPVWTJTATVJBR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL2180605","maximumClinicalTrialPhase":0,"parentId":"CHEMBL2220486","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"chEBI":["65138"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2181776","canonicalSmiles":"Cn1c(-c2ccccn2)c(C2CCCC2)c2ccc(C(=O)NC3(C(=O)Nc4ccc(/C=C/C(=O)O)cc4)CCC3)cc21","inchiKey":"JBSNALXXNTWUEC-SFQUDFHCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BILB-1941","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BILB 1941","BILB-1941ZW","Bilb-1941"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2218877","canonicalSmiles":"CCC(=O)O[C@H]1[C@H](O[C@@H]2[C@@H](C)[C@H](O[C@H]3C[C@@](C)(OC)[C@@H](O)[C@H](C)O3)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@]2(C)O)O[C@H](C)C[C@@H]1N(C)C.CCCCCCCCCCCCOS(=O)(=O)O","inchiKey":"AWMFUEJKWXESNL-JZBHMOKNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ERYTHROMYCIN ESTOLATE","yearOfFirstApproval":1967,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL2220427","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Erythromycin estolate","Ilosone"],"synonyms":["Erythromycin estolate","Erythromycin lauryl sulfate, propionyl","Erythromycin propionate lauryl sulfate","Propionyl erythromycin lauryl sulfate"],"crossReferences":{"PubChem":["144212546"],"chEBI":["4846"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1967."}
{"id":"CHEMBL2219642","canonicalSmiles":"[Cl-].[Cl-].[Mg+2]","inchiKey":"TWRXJAOTZQYOKJ-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"MAGNESIUM CHLORIDE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Magnesium chloride"],"crossReferences":{"DailyMed":["magnesium%20chloride"],"drugbank":["DB09407"],"chEBI":["6636"]},"childChemblIds":["CHEMBL3185229"],"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL224282","canonicalSmiles":"Cc1ccc(O)c(N)c1","inchiKey":"ZMXYNJXDULEQCK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL224282","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144207890","17389360","85147155"],"drugbank":["DB04533"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2347704","canonicalSmiles":"CC1(C)OB(O)c2cc(NC(=O)c3ccc(F)cc3C(F)(F)F)ccc21","inchiKey":"PTYGDEXEGLDNAZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ACOZIBOROLE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Acoziborole","SCTX-7158","SCYX-7158","Scyx-7158"],"crossReferences":{"drugbank":["DB13086"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL235363","canonicalSmiles":"CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCCN=C(N)N)C(N)=O","inchiKey":"ADNPLDHMAVUMIW-CUZNLEPHSA-N","drugType":"Protein","blackBoxWarning":false,"name":"SUBSTANCE P","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Substance p"],"crossReferences":{"PubChem":["50112420"],"Wikipedia":["Substance_P"]},"count":2,"description":"Protein drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2364619","canonicalSmiles":"C[N@+]1(CC2CC2)CC[C@]23CC(=O)CC[C@@]2(O)[C@H]1Cc1ccc(C(N)=O)c(O)c13","inchiKey":"ATCVVCBJNHXIEX-ZAHKBLQYSA-O","drugType":"Small molecule","blackBoxWarning":false,"name":"METHYLSAMIDORPHAN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ALKS 37","ALKS-37 CATION","Methylsamidorphan","RDC-1036 CATION","RDC-1036-00","RDC-103600","RDC-103603","Rdc-1036"],"crossReferences":{"drugbank":["DB15241"]},"childChemblIds":["CHEMBL2364620"],"count":1,"linkedTargets":{"rows":["ENSG00000112038"],"count":1},"linkedDiseases":{"rows":["HP_0002019"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL243731","canonicalSmiles":"O=C(O)COc1c(C(=O)O)sc(-c2cccc(NCc3ccccc3)c2)c1Br","inchiKey":"XEQPGVUGYAUMSA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL243731","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07289"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL248643","canonicalSmiles":"Oc1ccc(-c2cnc3ccc4ccncc4c3c2)cc1","inchiKey":"IUSSGTWHFMSCOY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL248643","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03623"],"chEBI":["40444"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL24983","canonicalSmiles":"O=c1oc(Cl)c(Cl)c2ccccc12","inchiKey":"SUGXUUGGLDCZKB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"3,4-Dichloroisocoumarin","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["3,4-Dichloroisocoumarin"],"crossReferences":{"PubChem":["11111099","26753564","50106222","57264275","85231012","90341353"],"drugbank":["DB04459"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL254328","canonicalSmiles":"C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@@]43C)[C@@H]1CC=C2c1cccnc1","inchiKey":"GZOSMCIZMLWJML-VJLLXTKPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ABIRATERONE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Zytiga"],"synonyms":["Abiraterone","CB 7598","CB-7598"],"crossReferences":{"Wikipedia":["Abiraterone"],"drugbank":["DB05812"],"chEBI":["68642"]},"count":6,"approvedIndications":["EFO_0000616","EFO_0000311"],"linkedTargets":{"rows":["ENSG00000148795","ENSG00000277893","ENSG00000128039","ENSG00000145545","ENSG00000169083"],"count":5},"linkedDiseases":{"rows":["EFO_0000616","EFO_0000196","EFO_0000673","MONDO_0008315","EFO_0001663","EFO_0000311"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for neoplasm and cancer and has 4 investigational indications."}
{"id":"CHEMBL267648","canonicalSmiles":"CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCN(C)CC3)cc21","inchiKey":"FHFYDNQZQSQIAI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PEFLOXACIN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["1589 RB","EU-5306","Pefloxacin"],"crossReferences":{"PubChem":["174006962"],"Wikipedia":["Pefloxacin"],"drugbank":["DB00487"],"chEBI":["50199"]},"childChemblIds":["CHEMBL3763640","CHEMBL1428564"],"count":1,"approvedIndications":["EFO_0000771"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for bacterial disease."}
{"id":"CHEMBL267894","canonicalSmiles":"CCC1(CCC(C)C)C(=O)N=C(O)NC1=O","inchiKey":"VIROVYVQCGLCII-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMOBARBITAL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["Norway"],"classes":["Misuse"],"year":1980},"tradeNames":["Amytal"],"synonyms":["Amobarbital","Amylobarbitone","Pentymal"],"crossReferences":{"PubChem":["144206419"],"Wikipedia":["Amobarbital"],"drugbank":["DB01351"],"chEBI":["2673"]},"childChemblIds":["CHEMBL2105941"],"description":"Small molecule drug with a maximum clinical trial phase of IV. It was withdrawn in Norway  in 1980 due to Misuse."}
{"id":"CHEMBL268254","canonicalSmiles":"O=C1CN=C(c2ccccc2Cl)c2cc(Cl)ccc2N1","inchiKey":"CHIFCDOIPRCHCF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DELORAZEPAM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Chlordesmethyldiazepam","Delorazepam"],"crossReferences":{"Wikipedia":["Delorazepam"],"drugbank":["DB01511"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL275528","canonicalSmiles":"c1ccc(C2(N3CCCCC3)CCCCC2)cc1","inchiKey":"JTJMJGYZQZDUJJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENCYCLIDINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Phencyclidine"],"crossReferences":{"Wikipedia":["Phencyclidine"],"drugbank":["DB03575"],"chEBI":["8058"]},"childChemblIds":["CHEMBL542581"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL276518","canonicalSmiles":"C1COCCN1","inchiKey":"YNAVUWVOSKDBBP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MORPHOLINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Morpholine"],"crossReferences":{"PubChem":["144209648","144213557"],"Wikipedia":["Morpholine"],"drugbank":["DB13669"],"chEBI":["34856"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL281594","canonicalSmiles":"Fc1ccc(C(OCCN2CCN(CCCc3ccccc3)CC2)c2ccc(F)cc2)cc1","inchiKey":"NAUWTFJOPJWYOT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VANOXERINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GBR 12909","GBR-12909","Vanoxerine"],"crossReferences":{"PubChem":["104171142","11111021","11111022","11113492","124879806","26751714","50104404","90341225"],"Wikipedia":["Vanoxerine"],"drugbank":["DB03701"],"chEBI":["64089"]},"childChemblIds":["CHEMBL153260","CHEMBL1973367","CHEMBL542933","CHEMBL543876"],"count":3,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL285123","canonicalSmiles":"N[C@H](CO)C(=O)O","inchiKey":"MTCFGRXMJLQNBG-UWTATZPHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"(D)-SERINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(d)-serine","D-Serine"],"crossReferences":{"PubChem":["144204821","26753645","26753646","50106988","90341480"],"drugbank":["DB03929"],"chEBI":["16523"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL285674","canonicalSmiles":"Clc1ccc2c(c1)C(c1ccccc1)=NCc1nncn1-2","inchiKey":"CDCHDCWJMGXXRH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"ESTAZOLAM","yearOfFirstApproval":1990,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Estazolam","Eurodin","Prosom"],"synonyms":["ABBOTT-47631","Estazolam","Estazolam civ","NSC-290818"],"crossReferences":{"DailyMed":["estazolam"],"PubChem":["144206162","50113063"],"Wikipedia":["Estazolam"],"drugbank":["DB01215"],"chEBI":["4858"]},"count":1,"approvedIndications":["EFO_0004698"],"linkedTargets":{"rows":["ENSG00000182256","ENSG00000022355","ENSG00000011677","ENSG00000113327","ENSG00000163285","ENSG00000151834","ENSG00000186297"],"count":7},"linkedDiseases":{"rows":["EFO_0004698"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1990 and is indicated for insomnia. This drug has a black box warning from the FDA."}
{"id":"CHEMBL291338","canonicalSmiles":"O=C(Nc1ccc(Cl)c(Cl)c1)c1cc(Cl)cc(Cl)c1O","inchiKey":"SJQBHPJLLIJASD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"3,3',4',5-TETRACHLOROSALICYLANILIDE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"]},"tradeNames":[],"synonyms":["3,3',4',5-tetrachlorosalicylanilide"],"crossReferences":{"PubChem":["144212390"],"chEBI":["188648"]},"description":"Small molecule drug with a maximum clinical trial phase of IV. It was withdrawn in United States."}
{"id":"CHEMBL298461","canonicalSmiles":"Clc1ccccc1Cl","inchiKey":"RFFLAFLAYFXFSW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"1,2-DICHLOROBENZENE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["1,2-Dichloro-Benzene","1,2-Dichlorobenzene"],"crossReferences":{"PubChem":["144204581","144209355","17389934"],"Wikipedia":["1,2-Dichlorobenzene"],"drugbank":["DB13963"],"chEBI":["35290"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3039512","canonicalSmiles":"COc1cc(NC(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)c(Cl)cc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12.O=C(O)CCC(=O)O","inchiKey":"BDWHLFQPZLPCIZ-XLQCLRHOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BATEFENTEROL SUCCINATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL3039518","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Batefenterol succinate","GSK961081D"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3039529","canonicalSmiles":"C#Cc1cnc2nc(O)n(C(CC)CC)c2n1","inchiKey":"RSQGZEAXODVTOL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TIRASEMTIV","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CK-2017357","CK2017357","Tirasemtiv"],"crossReferences":{"drugbank":["DB12209"]},"count":4,"linkedTargets":{"rows":["ENSG00000130595","ENSG00000101470","ENSG00000130598"],"count":3},"linkedDiseases":{"rows":["EFO_0000253","EFO_0004991","EFO_0003876","EFO_0004265"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL3039531","canonicalSmiles":"Cc1c(F)cccc1NC(=O)Nc1ccc(Cl)c(S(=O)(=O)[C@H]2CCCNC2)c1O","inchiKey":"NGYNBSHYFOFVLS-LBPRGKRZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DANIRIXIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Danirixin","GSK-1325756B","GSK1325756","GSK1325756B","Gsk1325756"],"crossReferences":{"drugbank":["DB11922"]},"childChemblIds":["CHEMBL4560026"],"count":3,"linkedTargets":{"rows":["ENSG00000180871"],"count":1},"linkedDiseases":{"rows":["EFO_1001413","EFO_0000341","EFO_0000763","MONDO_0024355"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL303984","canonicalSmiles":"CO[C@@H]1[C@@H](OC(=O)c2ccc(C)[nH]2)[C@@H](O)[C@H](Oc2ccc3c(O)c(NC(=O)c4ccc(O)c(CC=C(C)C)c4)c(=O)oc3c2Cl)OC1(C)C","inchiKey":"FJAQNRBDVKIIKK-LFLQOBSNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHLOROBIOCIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Clorobiocin"],"crossReferences":{"Wikipedia":["Clorobiocin"],"drugbank":["DB03966"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL307739","canonicalSmiles":"CNCCc1ccc(OC(=O)C(C)C)c(OC(=O)C(C)C)c1","inchiKey":"WDKXLLJDNUBYCY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IBOPAMINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ibopamine","SB 7505"],"crossReferences":{"drugbank":["DB13316"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3137314","canonicalSmiles":"CC#CC[C@H](C)[C@H](O)/C=C/[C@@H]1[C@H]2c3cccc(CCCC(=O)O)c3O[C@H]2C[C@H]1O","inchiKey":"CTPOHARTNNSRSR-NOQAJONNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ESUBERAPROST","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["APS-314d","Aps-314d","BPS-314d","Esuberaprost"],"childChemblIds":["CHEMBL3137337","CHEMBL4298145"],"count":1,"linkedTargets":{"rows":["ENSG00000160013"],"count":1},"linkedDiseases":{"rows":["EFO_0001361"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL3137346","drugType":"Enzyme","blackBoxWarning":false,"name":"PEGARGIMINASE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["0B7PYQ9YRT","ADI-PEG","ADI-PEG 20","ADI-PEG-20","ADI-PEG20","ADI-SS","ADIPEG20","PEG 20","Pegargiminase"],"count":11,"description":"Enzyme drug with a maximum clinical trial phase of II (across all indications) and has 11 investigational indications."}
{"id":"CHEMBL32113","canonicalSmiles":"COc1ccc(OC)c(CN(C)c2cnc3nc(N)nc(N)c3c2)c1","inchiKey":"HZTFNSCZLJLPEO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL32113","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02583"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3216899","canonicalSmiles":"Cc1cc(Cn2nnc3c(-c4ccco4)nc(N)nc32)ccc1N.Cl.Cl","inchiKey":"VLGPGUNBWYNPBT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3216899","maximumClinicalTrialPhase":0,"parentId":"CHEMBL447664","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL321944","canonicalSmiles":"COc1ccc2ccc(C(=N)N)cc2c1-c1cnn(S(C)(=O)=O)c1","inchiKey":"KQUXAFOLFXHVQN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL321944","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03046"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3249110","canonicalSmiles":"COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(CCO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1","inchiKey":"RGVRUQHYQSORBY-JIGXQNLBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"13-DEOXYDOXORUBICIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["13-deoxydoxorubicin","GPX-100","Gpx-100"],"crossReferences":{"drugbank":["DB05706"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3301577","drugType":"Protein","blackBoxWarning":false,"name":"IPAFRICEPT","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ipafricept","OMP-54F28"],"count":1,"linkedTargets":{"rows":["ENSG00000177283"],"count":1},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Protein drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3301586","drugType":"Antibody","blackBoxWarning":false,"name":"CLIVATUZUMAB TETRAXETAN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Clivatucyn"],"synonyms":["Clivatuzumab tetraxetan","HPAM-4","IMMU-107","IgG-DOTA","hPAM4"],"count":1,"linkedTargets":{"rows":["ENSG00000215182"],"count":1},"linkedDiseases":{"rows":["EFO_0002618","EFO_1000044"],"count":2},"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3301593","canonicalSmiles":"Nc1ccc(C#Cc2cnn3c(C(F)(F)F)cc(-c4ccc(C(F)(F)F)cc4)nc23)cn1","inchiKey":"DMJHZVARRXJSEG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DECOGLURANT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Decoglurant","RO-4995819","RO4995819","Rg1578"],"crossReferences":{"drugbank":["DB11923"]},"count":2,"linkedTargets":{"rows":["ENSG00000164082","ENSG00000198822"],"count":2},"linkedDiseases":{"rows":["MONDO_0002009"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL332958","canonicalSmiles":"Cc1ccc(S(=O)(=O)N(C)c2ccnn2-c2ccccc2)cc1","inchiKey":"KRHPBWNETCEFGS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL332958","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07670"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL333964","canonicalSmiles":"N[C@@H](Cn1cc(Br)c(=O)[nH]c1=O)C(=O)O","inchiKey":"AEKIJKSVXKWGRJ-BYPYZUCNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL333964","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04000"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3544937","canonicalSmiles":"COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCn1ccnn1.Cl","inchiKey":"IOFHDGSCWJNVRZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ZD-4190","maximumClinicalTrialPhase":1,"parentId":"CHEMBL281872","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Zd-4190"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545031","drugType":"Small molecule","blackBoxWarning":false,"name":"MK-1029","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mk-1029"],"count":1,"linkedTargets":{"rows":["ENSG00000183134"],"count":1},"linkedDiseases":{"rows":["EFO_0000270"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3545076","canonicalSmiles":"Cn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc3[nH]ncc23)CC1","inchiKey":"FYXRSVDHGLUMHB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LY-2584702","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LY 2584702","LY2584702","Ly-2584702"],"crossReferences":{"drugbank":["DB12690"]},"childChemblIds":["CHEMBL3911801","CHEMBL3909070"],"count":4,"linkedTargets":{"rows":["ENSG00000108443"],"count":1},"linkedDiseases":{"rows":["EFO_1001901","EFO_0000681","EFO_0003060","EFO_0000311","EFO_0009708"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL3545084","drugType":"Small molecule","blackBoxWarning":false,"name":"TCD-717","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tcd-717"],"count":1,"linkedTargets":{"rows":["ENSG00000110721"],"count":1},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3545173","drugType":"Small molecule","blackBoxWarning":false,"name":"IRX4310","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Irx4310"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545190","drugType":"Unknown","blackBoxWarning":false,"name":"ISUNAKINRA","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["EBI-005","Isunakinra"],"count":3,"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3545224","canonicalSmiles":"Nc1cc(N2CCN(CCP(=O)(O)O)CC2)nc(NCC2CCC(CNCCCNC3CCCCC3)CC2)n1","inchiKey":"QLVSJMZJSABWRX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BURIXAFOR","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Burixafor","Tg-0054"],"count":4,"linkedTargets":{"rows":["ENSG00000121966"],"count":1},"linkedDiseases":{"rows":["EFO_0001378","EFO_0000183","EFO_0005952","MONDO_0008315"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL3545276","drugType":"Small molecule","blackBoxWarning":false,"name":"CP-778875","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cp-778875"],"count":1,"linkedTargets":{"rows":["ENSG00000186951"],"count":1},"linkedDiseases":{"rows":["Orphanet_309005"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3545356","drugType":"Small molecule","blackBoxWarning":false,"name":"VK5211","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LGD-4033","Vk5211"],"count":1,"linkedTargets":{"rows":["ENSG00000169083"],"count":1},"linkedDiseases":{"rows":["EFO_0003964"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL362811","canonicalSmiles":"N#Cc1cccc(S(=O)(=O)N2C[C@@H](O)[C@@H](Cc3ccccc3)N(Cc3ccc(O)cc3)C(=O)N2Cc2ccc(O)cc2)c1","inchiKey":"UYUWNNRWESUYOB-FIRIVFDPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL362811","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03141"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL363295","canonicalSmiles":"CC(CC(c1ccccc1)c1ccccc1)NC(C)(C)C","inchiKey":"UISARWKNNNHPGI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TERODILINE","yearOfFirstApproval":1986,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["Germany"," Spain"," United Kingdom"],"classes":["Cardiotoxicity"],"year":1991},"tradeNames":[],"synonyms":["Terodiline"],"crossReferences":{"Wikipedia":["Terodiline"],"drugbank":["DB13725"]},"childChemblIds":["CHEMBL539770"],"count":2,"approvedIndications":["HP_0000020","HP_0000103"],"linkedTargets":{"rows":["ENSG00000157388","ENSG00000157445","ENSG00000165995","ENSG00000198216","ENSG00000167535","ENSG00000007402","ENSG00000180720","ENSG00000081248","ENSG00000141837","ENSG00000130433","ENSG00000182389","ENSG00000184984","ENSG00000075461","ENSG00000142408","ENSG00000100346","ENSG00000151067","ENSG00000166862","ENSG00000148408","ENSG00000105605","ENSG00000133019","ENSG00000006116","ENSG00000168539","ENSG00000102001","ENSG00000151062","ENSG00000108878","ENSG00000006283","ENSG00000075429","ENSG00000196557","ENSG00000153956","ENSG00000181072","ENSG00000067191"],"count":31},"linkedDiseases":{"rows":["HP_0000020","HP_0000103"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1986 and is indicated for polyuria and urinary incontinence. It was withdrawn in Germany,  Spain and  United Kingdom initially in 1991 due to Cardiotoxicity."}
{"id":"CHEMBL363498","canonicalSmiles":"N#Cc1cc(O)cc2cc(-c3ccc(O)cc3)oc12","inchiKey":"GGEKOZPXKBYLNK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL363498","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07198"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3701238","canonicalSmiles":"C=CC(=O)N1CC[C@H](n2nc(C#Cc3cc(OC)cc(OC)c3)c3c(N)ncnc32)C1","inchiKey":"KEIPNCCJPRMIAX-HNNXBMFYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FUTIBATINIB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Futibatinib","TAS-120","Tas 120","Tas-120"],"crossReferences":{"drugbank":["DB15149"]},"count":4,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL3707222","canonicalSmiles":"CCCC[C@]1(CC)CS(=O)(=O)c2ccc(N(C)C)cc2[C@@H](c2cccc(NC(=O)N[C@@H]3O[C@H](COS(=O)(=O)O)[C@@H](O)[C@H](OCc4ccccc4)[C@H]3O)c2)[C@H]1O","inchiKey":"ULVBLFBUTQMAGZ-RTNCXNSASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VOLIXIBAT","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SAR-548304 FREE ACID","Volixibat"],"crossReferences":{"drugbank":["DB13914"]},"childChemblIds":["CHEMBL3707221","CHEMBL3956446"],"linkedTargets":{"rows":["ENSG00000125255"],"count":1},"linkedDiseases":{"rows":["EFO_0004268"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL372357","canonicalSmiles":"O=c1c(C2=Nc3ccccc3S(=O)(=O)N2)c(O)c2cc(F)ccc2n1CCC1CC1","inchiKey":"QEMCDXCXSVPAAB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL372357","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08278"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL372638","canonicalSmiles":"N#Cc1ccc(-c2cc(C3CC4CCC3N4)cnc2F)cc1","inchiKey":"HMZQULPVMKITSP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL372638","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"Wikipedia":["Furafylline"],"drugbank":["DB14029"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL378544","canonicalSmiles":"CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1.O=S(=O)(O)O","inchiKey":"KDQAABAKXDWYSZ-PNYVAJAMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VINBLASTINE SULFATE","yearOfFirstApproval":1965,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL159","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Velban","Velbe","Vinblast,lederle","Vinblastine sulfate"],"synonyms":["29060-LE","29060LE","NSC-49842","Vinblastine sulfate"],"crossReferences":{"DailyMed":["vinblastine%20sulfate"],"PubChem":["144205051","144206288","170464976","170464977","26663016","56462989","855758"]},"count":15,"linkedTargets":{"rows":["ENSG00000261456","ENSG00000188229","ENSG00000104833","ENSG00000137267","ENSG00000258947","ENSG00000101162","ENSG00000137285","ENSG00000196230","ENSG00000176014"],"count":9},"linkedDiseases":{"rows":["MONDO_0009348","MONDO_0007608","EFO_0000292","EFO_0004281","MONDO_0003751","MONDO_0004192","EFO_0000756","MONDO_0008170","MONDO_0008315","EFO_0003060","MONDO_0020654","MONDO_0001187","EFO_0000588","MONDO_0018201","MONDO_0002974","EFO_0000389","MONDO_0008903","EFO_0000574","MONDO_0002367","EFO_0006544","EFO_0000691"],"count":21},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1965 and has 15 investigational indications."}
{"id":"CHEMBL3809489","canonicalSmiles":"Nc1nc(Nc2ccc3c(c2)CC[C@@H](N2CCCC2)CC3)nn1-c1cc2c(nn1)-c1ccccc1CCC2","inchiKey":"KXMZDGSRSGHMMK-VWLOTQADSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BEMCENTINIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BGB 324","BGB-324","BGB324","Bemcentinib","CS-1046","HY-15150","KB-80319","QC-11751","R 428","R-428","R428","SYN-1131","SYN1131","W-5845"],"crossReferences":{"drugbank":["DB12411"]},"count":9,"linkedTargets":{"rows":["ENSG00000167601"],"count":1},"linkedDiseases":{"rows":["EFO_0000198","EFO_0002618","EFO_0000588","EFO_0000756","EFO_0000571","EFO_0000222","EFO_0003060","EFO_1000984","EFO_1000158"],"count":9},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 9 investigational indications."}
{"id":"CHEMBL3833302","canonicalSmiles":"C/C=C/C(=O)N(CC)C(CC)C(=O)N(C)C.C/C=C/C(=O)N(CCC)C(CC)C(=O)N(C)C","inchiKey":"ZDHWSRRZUPRQBD-ACOOBTJJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PRETHCAMIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Prethcamide"],"crossReferences":{"DrugCentral":["4333"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3833342","drugType":"Oligonucleotide","blackBoxWarning":false,"name":"NUSINERSEN SODIUM","yearOfFirstApproval":2016,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Spinraza"],"synonyms":["Nusinersen sodium"],"crossReferences":{"DailyMed":["nusinersen%20sodium"]},"description":"Oligonucleotide drug with a maximum clinical trial phase of IV that was first approved in 2016."}
{"id":"CHEMBL3833370","canonicalSmiles":"Cc1cc(O)cc(C)c1C[C@H](NC(=O)[C@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(N)=O","inchiKey":"SFVLTCAESLKEHH-WKAQUBQDSA-N","drugType":"Protein","blackBoxWarning":false,"name":"ELAMIPRETIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Elamipretide","MTP 131","MTP-131","RX 31","RX-31","SS 31","SS-31"],"crossReferences":{"drugbank":["DB11981"]},"childChemblIds":["CHEMBL4298161"],"count":8,"description":"Protein drug with a maximum clinical trial phase of III (across all indications) and has 8 investigational indications."}
{"id":"CHEMBL3919709","canonicalSmiles":"[2H]C([2H])([2H])n1cc(-c2cnc3ccc(N(CCNC(C)C)c4cc(OC)cc(OC)c4)cc3n2)cn1","inchiKey":"OLAHOMJCDNXHFI-HPRDVNIFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3919709","maximumClinicalTrialPhase":0,"parentId":"CHEMBL3545376","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3989663","canonicalSmiles":"C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)COC(=O)CCC(=O)O.O","inchiKey":"AFLWPAGYTPJSEY-CODXZCKSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HYDROCORTISONE HEMISUCCINATE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL977","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Hydrocortisone hemisuccinate","Hydrocortisone succinate"],"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL3989689","canonicalSmiles":"CC(C)[C@@H](CC[C@@H](C)[C@H]1CC[C@H]2[C@H]3[C@H](CC[C@@]21C)[C@@]1(C)CC[C@H](NCCCNCCCCN)C[C@@H]1C[C@H]3O)OS(=O)(=O)O.C[C@H](O)C(=O)O.O","inchiKey":"ZPYIELFRIYUVQP-BHBJEIPNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SQUALAMINE LACTATE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL444929","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MSI-1256F","Squalamine lactate"],"count":5,"linkedTargets":{"rows":["ENSG00000066230"],"count":1},"linkedDiseases":{"rows":["EFO_0009606","EFO_0001365","MONDO_0008170","EFO_0003770","MONDO_0008315"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL404215","canonicalSmiles":"OC(CCN1CCCCC1)(c1ccccc1)c1ccccc1","inchiKey":"RQXCLMGKHJWMOA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PRIDINOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["C-238","Pridinol","Pridinol mesilate"],"crossReferences":{"PubChem":["144203573","170465865","4252736","50100154","50104209","50104210","50104211","84992"],"Wikipedia":["Pridinol"],"drugbank":["DB13642"],"chEBI":["75247"]},"childChemblIds":["CHEMBL1528011"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL41036","canonicalSmiles":"CC(C)c1cc(Oc2c(Cl)cc(CC(=O)O)cc2Cl)ccc1O","inchiKey":"OZYQIQVPUZANTM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL41036","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03176"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL411274","canonicalSmiles":"O=P(O)(O)C(O)(Cc1cccc(-c2cccc3c2oc2ccccc23)c1)P(=O)(O)O","inchiKey":"BYVXAUZOTGITQZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BPH-629","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BPH-629"],"crossReferences":{"drugbank":["DB07410"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4290012","canonicalSmiles":"CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1.CS(=O)(=O)O","inchiKey":"NCJPFQPEVDHJAZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL4290012","maximumClinicalTrialPhase":0,"parentId":"CHEMBL3301610","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4297377","canonicalSmiles":"CCC(=O)[N-]S(=O)(=O)c1ccc(NC(=O)Cc2ccc(Br)c(Oc3cc(Cl)cc(C#N)c3)c2F)c(Cl)c1.[Na+]","inchiKey":"UJFARQSHFFWJHD-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"ELSULFAVIRINE SODIUM","maximumClinicalTrialPhase":1,"parentId":"CHEMBL4301163","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Elpida","Elsulfavirine sodium","R-1206 SODIUM","R1206(SODIUM SALT)"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297394","canonicalSmiles":"C=C(C#N)C(=O)OCCC(C)C","inchiKey":"GASDVTHQNCFANM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ISOPENTYL 2-CYANOACRYLATE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Isoamyl 2-cyanoacrylate","Isopentyl 2-cyanoacrylate"],"crossReferences":{"drugbank":["DB12630"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297438","canonicalSmiles":"O=C(O)/C=C\\C(=O)O.OC1CN(CCCOCCc2ccc3sccc3c2)C1","inchiKey":"RLUCYBFCLXANSO-BTJKTKAUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"T-817 MALEATE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL4302089","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["J2.179.155E","T-817 maleate","T-817MA","T-817ma"],"count":3,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297455","canonicalSmiles":"O=C(O)Cc1nn(Cc2nc3cc(C(F)(F)F)ccc3s2)c(=O)c2nccnc12","inchiKey":"YRGPAXAVTDMKDK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AT-001","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AT-001","At-001"],"crossReferences":{"drugbank":["DB15121"]},"description":"Small molecule drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL4297498","canonicalSmiles":"FC(F)(F)c1cccc(C2=CCN(CCc3ccc4ccncc4c3)CC2)c1","inchiKey":"ZXXHOPNSTZKWRI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SSR-150106","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SSR-150106","SSR-150106XB","SSR150106","SSR150106XB","Ssr-150106","Ssr150106"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297573","drugType":"Protein","blackBoxWarning":true,"name":"TAGRAXOFUSP","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Elzonris"],"synonyms":["DT-3881L3","DT388IL3","MOLECULE-129","Molecule 129","SL-401","Sl-401","Tagraxofusp","Tagraxofusp-erzs"],"crossReferences":{"DailyMed":["tagraxofusp-erzs"]},"count":3,"approvedIndications":["EFO_0000616","EFO_0000222"],"linkedTargets":{"rows":["ENSG00000167658","ENSG00000185291"],"count":2},"linkedDiseases":{"rows":["EFO_0000198","EFO_0000616","EFO_0000222","EFO_0010580"],"count":4},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2018 and is indicated for acute myeloid leukemia and neoplasm and has 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL4297578","drugType":"Protein","blackBoxWarning":false,"name":"PEGBELFERMIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ARX-618","BMS-986036","Bms-986036","Pegbelfermin"],"count":3,"description":"Protein drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297610","canonicalSmiles":"C[C@H](Nc1ccc(C#N)n(C)c1=O)c1cc2cc(Cl)ccc2[nH]c1=O","inchiKey":"NEQYWYXGTJDAKR-JTQLQIEISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OLUTASIDENIB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["FT-2102","Ft-2102","Olutasidenib"],"count":2,"linkedTargets":{"rows":["ENSG00000138413"],"count":1},"linkedDiseases":{"rows":["EFO_0000198","EFO_0000222"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297760","drugType":"Oligonucleotide","blackBoxWarning":false,"name":"GIVOSIRAN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ALN-AS1","Givosiran"],"count":2,"linkedTargets":{"rows":["ENSG00000023330"],"count":1},"linkedDiseases":{"rows":["Orphanet_100924","Orphanet_79276","Orphanet_79273"],"count":3},"description":"Oligonucleotide drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297858","drugType":"Antibody","blackBoxWarning":false,"name":"BUDIGALIMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ABBV-181","ABBV181","Abbv-181","Budigalimab","PR-1648817"],"count":8,"description":"Antibody drug with a maximum clinical trial phase of I (across all indications) and has 8 investigational indications."}
{"id":"CHEMBL4297869","drugType":"Unknown","blackBoxWarning":false,"name":"COAGULATION FACTOR VIIA RECOMBINANT HUMAN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Activated recombinant human factor vii","Coagulation factor viia (recombinant)","Coagulation factor viia recombinant human","Eptacog alfa (activated)","Eptacog beta (activated)","Recombinant activated factor vii"],"count":7,"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL4297898","drugType":"Unknown","blackBoxWarning":false,"name":"AVIDIN PERIODATE OXIDIZED","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Avidin periodate oxidized","Avidinox"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297904","drugType":"Unknown","blackBoxWarning":false,"name":"BAY-1093884","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BAY-1093884","BAY1093884","Bay-1093884","Bay1093884","Befovacimab"],"count":3,"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297933","drugType":"Unknown","blackBoxWarning":false,"name":"DHES-0815A","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dhes-0815a","Dhes0815a"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4298001","drugType":"Antibody","blackBoxWarning":false,"name":"CETRELIMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cetrelimab","JNJ-63723283","JNJ63723283","Jnj 63723283","Jnj-63723283"],"count":4,"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL4298052","drugType":"Small molecule","blackBoxWarning":false,"name":"DEMPLATIN PEGRAGLUMER","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Demplatin pegraglumer","NC-6004","NC-6004 NANOPLATIN","Nc-6004"],"count":5,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL4303424","canonicalSmiles":"CC(COc1ccccc1)NN.Cl.Cl","inchiKey":"ICESXWSYSZBABF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL4303424","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1909286","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL432359","canonicalSmiles":"CC(=O)N[C@@H](Cc1ccc(CC(=O)O)c(C(=O)O)c1)C(=O)N[C@H]1CCCCN(Cc2ccc(-c3ccccc3)cc2)C1=O","inchiKey":"CEKLBQMULVLLTD-VMPREFPWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL432359","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03712"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL436","canonicalSmiles":"COc1ccc2c(C(=S)N(C)CC(=O)O)cccc2c1C(F)(F)F","inchiKey":"LUBHDINQXIHVLS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TOLRESTAT","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["Canada"," Italy"," Argentina"],"classes":["Hepatotoxicity"],"year":1996},"tradeNames":["Alderase","Alredase"],"synonyms":["AY-27,773","AY-27773","Tolrestat"],"crossReferences":{"PubChem":["144206867"],"Wikipedia":["Tolrestat"],"drugbank":["DB02383"],"chEBI":["48549"]},"count":1,"approvedIndications":["EFO_0000400"],"linkedTargets":{"rows":["ENSG00000085662"],"count":1},"linkedDiseases":{"rows":["EFO_0000400"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for diabetes mellitus. It was withdrawn in Canada,  Italy and  Argentina initially in 1996 due to Hepatotoxicity."}
{"id":"CHEMBL437557","canonicalSmiles":"CN(C)C(=O)[C@@H]([C@H]1CC[C@H](c2ccc3ncnn3c2)CC1)[C@H](N)C(=O)N1CCC(F)(F)C1","inchiKey":"JNAZOMVWUGPITI-LNMJFAINSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL437557","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07092"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL441738","canonicalSmiles":"CCCC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(C)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(N)=O)C(C)C","inchiKey":"UAHFGYDRQSXQEB-LEBBXHLNSA-N","drugType":"Protein","blackBoxWarning":false,"name":"AFAMELANOTIDE","yearOfFirstApproval":2019,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Scenesse"],"synonyms":["Afamelanotide","CUV-1647","CUV1647"],"crossReferences":{"DailyMed":["afamelanotide"],"Wikipedia":["Afamelanotide"],"drugbank":["DB04931"]},"childChemblIds":["CHEMBL4297213"],"count":3,"approvedIndications":["Orphanet_79278"],"linkedTargets":{"rows":["ENSG00000258839"],"count":1},"linkedDiseases":{"rows":["EFO_0005531","EFO_0004208","Orphanet_79278"],"count":3},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2019 and is indicated for erythropoietic protoporphyria and has 2 investigational indications."}
{"id":"CHEMBL445245","canonicalSmiles":"CCc1ccsc1-c1ccc(O)c(O)c1","inchiKey":"VXLXQOMDQVQQLA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL445245","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08718"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL447664","canonicalSmiles":"Cc1cc(Cn2nnc3c(-c4ccco4)nc(N)nc32)ccc1N","inchiKey":"HQSBCDPYXDGTCL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VIPADENANT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BIIB-014","BIIB014","Biib014","CEB-4520","V-2006","V2006","VER-11135","VER-A-00-11","VER-A-00049","VER-A00-11","VER-A00049","VER-ADO-49","Vipadenant"],"crossReferences":{"drugbank":["DB06625"]},"childChemblIds":["CHEMBL3216899","CHEMBL461006"],"count":1,"linkedTargets":{"rows":["ENSG00000128271"],"count":1},"linkedDiseases":{"rows":["EFO_0002508"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL44793","canonicalSmiles":"O=C(/C=C/c1c(C(=O)O)[nH]c2cc(Cl)cc(Cl)c12)Nc1ccccc1","inchiKey":"WZBNEZWCNKUOSM-VOTSOKGWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GAVESTINEL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GV 150526X","Gavestinel"],"crossReferences":{"drugbank":["DB06741"]},"childChemblIds":["CHEMBL419045"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL451721","canonicalSmiles":"CCCCC[C@H](O)/C=C/C=C\\CCCCCCCC(=O)O","inchiKey":"HNICUWMFWZBIFP-IRQZEAMPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"(S)-Coriolic Acid","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(S)-Coriolic Acid"],"crossReferences":{"PubChem":["26754875","26754876"],"drugbank":["DB06926"],"chEBI":["34154"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL455917","canonicalSmiles":"OC(O)C(Cl)(Cl)Cl","inchiKey":"RNFNDJAIBTYOQL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHLORAL HYDRATE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Noctec","Sk-chloral hydrate"],"synonyms":["Chloral Hydrate","Chloral hydrate","NSC-3210"],"crossReferences":{"PubChem":["144205167","144207308","170465484","29215298"],"Wikipedia":["Chloral_hydrate"],"drugbank":["DB01563"],"chEBI":["28142"]},"count":5,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL456649","canonicalSmiles":"N#Cc1cc(Cl)cc(Oc2c(Br)ccc(Cc3n[nH]c4nnccc34)c2F)c1","inchiKey":"OHQMEDBYNUAVNE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL456649","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08446"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4584965","canonicalSmiles":"Cl[TeH]1(Cl)(Cl)OCCO1.N","inchiKey":"DXZFFLRJVDZCMT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMMONIUM TRICHLOROTELLURATE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL4597200","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AS-101","AS101","Ammonium trichlorotellurate","As101"],"count":7,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL459","canonicalSmiles":"C[C@](N)(Cc1ccc(O)c(O)c1)C(=O)O","inchiKey":"CJCSPKMFHVPWAR-JTQLQIEISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHYLDOPA","yearOfFirstApproval":1962,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aldomet","Dopamet","Lederdopa","Medomet","Metalpha 250","Metalpha 500","Methyldopa"],"synonyms":["Alpha-methyldopa","BAYER-1440L","J9.247I","MK-351","Methyldopa","Methyldopa (levorotatory)","Methyldopa hydrate","Methyldopa sesquihydrate","NSC-169916"],"crossReferences":{"DailyMed":["methyldopa"],"PubChem":["11113581","124886927","144209808","50104474","8139902","90341702"],"TG-GATEs":["56"],"Wikipedia":["Methyldopa"],"drugbank":["DB00968"],"chEBI":["61058"]},"childChemblIds":["CHEMBL4063475","CHEMBL1591707"],"count":3,"approvedIndications":["EFO_0000537"],"linkedTargets":{"rows":["ENSG00000274286","ENSG00000184160","ENSG00000150594"],"count":3},"linkedDiseases":{"rows":["EFO_0001359","EFO_0000668","EFO_0000537"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1962 and is indicated for hypertension and has 2 investigational indications."}
{"id":"CHEMBL4590319","canonicalSmiles":"COc1ccc2c(c1)c(CC(=O)O)c(C)n2C(=O)c1ccc(Cl)cc1.O","inchiKey":"SAXHGNLFQAIQSA-UHFFFAOYSA-N","drugType":"unknown","blackBoxWarning":false,"name":"CHEMBL4590319","maximumClinicalTrialPhase":0,"parentId":"CHEMBL6","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Unknown drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4594293","canonicalSmiles":"CC#CC(=O)N1CCC[C@H]1c1nc(-c2ccc(C(=O)Nc3ccccn3)cc2)c2c(N)nccn12.O=C(O)/C=C\\C(=O)O","inchiKey":"JWEQLWMZHJSMEC-AFJTUFCWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ACALABRUTINIB MALEATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL3707348","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Calquence"],"synonyms":["Acalabrutinib maleate"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4594417","canonicalSmiles":"CC1(C)C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2F)C(=S)N1c1ccc(CCCc2ncco2)nc1","inchiKey":"KCBJGVDOSBKVKP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GT-0918","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Gt-0918","Proxalutamide"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4594542","drugType":"Protein","blackBoxWarning":false,"name":"EFLEPEDOCOKIN ALFA","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Eflepedocokin alfa","F-652"],"count":1,"description":"Protein drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4594606","drugType":"Unknown","blackBoxWarning":false,"name":"ANTI-PSGL-1 ANTIBODY SELK2","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Anti-psgl-1 antibody selk2","Selk2"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL463981","canonicalSmiles":"O=S(=O)(N[C@H](CO)C(C(F)(F)F)C(F)(F)F)c1ccc(Cl)s1","inchiKey":"PSXOKXJMVRSARX-SCSAIBSYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BEGACESTAT","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Begacestat","GSI-953"],"crossReferences":{"drugbank":["DB12263"]},"count":1,"linkedTargets":{"rows":["ENSG00000205155","ENSG00000138613","ENSG00000162736","ENSG00000080815","ENSG00000143801","ENSG00000117362"],"count":6},"linkedDiseases":{"rows":["EFO_0000249"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL478858","canonicalSmiles":"CCCCCCCCN1CCc2c(C)c(CC(=O)O)c(C)c(NC(=O)C(C)(C)C)c21","inchiKey":"TXIIZHHIOHVWJD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PACTIMIBE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pactimibe"],"crossReferences":{"drugbank":["DB12971"]},"childChemblIds":["CHEMBL564483","CHEMBL447977"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL485652","canonicalSmiles":"Cc1cn([C@H]2C=C[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O2)c(=O)[nH]c1=O","inchiKey":"ODSQODTUNULBHF-JGVFFNPUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"STAVUDINE TRIPHOSPHATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Stavudine triphosphate"],"crossReferences":{"drugbank":["DB02887"]},"childChemblIds":["CHEMBL320969"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL491841","canonicalSmiles":"O=C(O)c1[nH]c(C(=O)O)c(-c2c[nH]c3ccccc23)c1-c1c[nH]c2ccccc12","inchiKey":"FZDVNXHYGMEEDT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LYCOGALIC ACID A","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07588"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL500779","canonicalSmiles":"Nc1n[nH]c2ccc(-c3ccccc3)cc12","inchiKey":"ZCUSNQPYUNLATP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL500779","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07161"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL520733","canonicalSmiles":"CC(C)[C@H](O)C(=O)N[C@@H](C)C(=O)N[C@@H]1C(=O)N(C)CCc2ccccc21","inchiKey":"PKXWXXPNHIWQHW-RCBQFDQVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SEMAGACESTAT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LY-450139","LY450139","Semagacestat"],"crossReferences":{"Wikipedia":["Semagacestat"],"drugbank":["DB12463"]},"count":1,"linkedTargets":{"rows":["ENSG00000205155","ENSG00000138613","ENSG00000162736","ENSG00000080815","ENSG00000143801","ENSG00000117362"],"count":6},"linkedDiseases":{"rows":["EFO_0000249"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL521105","canonicalSmiles":"CCCCNC(=O)c1cccc(NC(=O)CCCCCNc2ncnc3[nH]cnc23)c1","inchiKey":"WOYITRCGMUXUDE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL521105","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07801"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL522987","canonicalSmiles":"Cc1cc(F)ccc1[C@H]1CNCCN1C(=O)N(C)[C@H](C)c1cc(C(F)(F)F)cc(C(F)(F)F)c1","inchiKey":"SBBYBXSFWOLDDG-JLTOFOAXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VESTIPITANT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GW-597599","Vestipitant"],"crossReferences":{"Wikipedia":["Vestipitant"],"drugbank":["DB11949"]},"childChemblIds":["CHEMBL2104992"],"count":7,"linkedTargets":{"rows":["ENSG00000115353"],"count":1},"linkedDiseases":{"rows":["HP_0000360","MONDO_0002050","MONDO_0002009","EFO_0004888","EFO_0008568","EFO_1001917","EFO_0004698"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL54277","canonicalSmiles":"O=[N+]([O-])c1ccc2cn[nH]c2c1","inchiKey":"ORZRMRUXSPNQQL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL54277","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["11113657","56423145","8139969"],"drugbank":["DB03100"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL54440","canonicalSmiles":"CC[C@H](C)C(=O)O[C@H]1CCC=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21","inchiKey":"AJLFOPYRIVGYMJ-INTXDZFKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MEVASTATIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mevastatin"],"crossReferences":{"PubChem":["144205093","24820212","26719712","89850273","90340823"],"Wikipedia":["Mevastatin"],"drugbank":["DB06693"],"chEBI":["34848"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL55771","canonicalSmiles":"C[C@@H](NC(=O)c1ccccc1)C(=O)O","inchiKey":"UAQVHNZEONHPQG-SSDOTTSWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"2-Benzoylamino-Propionic Acid","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2-Benzoylamino-Propionic Acid","Benzoyl-D-Alanine"],"crossReferences":{"drugbank":["DB08508"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL584852","canonicalSmiles":"CCOC(=O)c1cnc2cc(OCC(C)C)c(OCC(C)C)cc2c1O","inchiKey":"LVVXOXRUTDAKFE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BUQUINOLATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Buquinolate","EU-1093","GNF-Pf-1188"],"crossReferences":{"PubChem":["144206110","50112816"],"drugbank":["DB11378"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL590540","canonicalSmiles":"N[C@@H](CSSC[C@H](N)C(=O)O)C(=O)O","inchiKey":"LEVWYRKDKASIDU-IMJSIDKUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CYSTINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Cystine"],"crossReferences":{"PubChem":["144205715","170465457","29217764"],"drugbank":["DB00138"],"chEBI":["16283"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL590754","canonicalSmiles":"COc1ccc(/C(C)=N/OC(N)=O)cc1OC1CCCC1","inchiKey":"STTRYQAGHGJXJJ-LICLKQGHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FILAMINAST","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Filaminast","WAY-PDA-641"],"crossReferences":{"drugbank":["DB02660"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL593602","canonicalSmiles":"O=C(O)CCN1C(=O)/C(=C\\c2ccc(-c3ccc(Cl)cc3)o2)SC1=S","inchiKey":"YZLFZFALAZYTCI-NTEUORMPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL593602","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08177"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL596","canonicalSmiles":"CCC(=O)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1","inchiKey":"PJMPHNIQZUBGLI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"FENTANYL","yearOfFirstApproval":1968,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Abstral","Actiq","Breakyl","Duragesic","Duragesic-100","Duragesic-12","Duragesic-25","Duragesic-37","Duragesic-50","Duragesic-75","Durogesic","Durogesic dtrans","Effentora","Fencino","Fentalis reservoir","Fentanyl-100","Fentanyl-12","Fentanyl-25","Fentanyl-37","Fentanyl-50","Fentanyl-62","Fentanyl-75","Fentanyl-87","Fentora","Ionsys","Leptanal","Matrifen","Mezolar matrix","Mylafent","Opiodur","Oralet","Osmach","Osmanil","Pecfent","Recivit","Sublimaze","Subsys","Tilofyl","Victanyl","Yemex"],"synonyms":["AD 923","AD-923","Fentanyl","Fentanyl cii","Fentora","IDS-NF-001","Innovar","Ionsys","N02AB03","R 4263"],"crossReferences":{"DailyMed":["fentanyl","fentanyl%20citrate"],"PubChem":["144206164","50113065"],"Wikipedia":["Fentanyl"],"drugbank":["DB00813"],"chEBI":["119915"]},"childChemblIds":["CHEMBL688","CHEMBL1201159"],"count":26,"approvedIndications":["HP_0012532","EFO_0003843","EFO_0000311"],"linkedTargets":{"rows":["ENSG00000112038"],"count":1},"linkedDiseases":{"rows":["EFO_1001139","EFO_0003777","HP_0012735","EFO_0000555","EFO_0003964","EFO_0009727","HP_0100543","EFO_0003931","EFO_0002506","EFO_0008585","MONDO_0021666","EFO_0004616","EFO_0004244","HP_0003419","EFO_0009870","EFO_0005762","EFO_0002618","HP_0002093","EFO_0001074","HP_0012532","EFO_0005323","EFO_0003821","MONDO_0008315","EFO_0000546","EFO_0001422","EFO_0003841","HP_0002045","EFO_0009842","EFO_0004888","HP_0001336","EFO_0004209","EFO_0000341","HP_0025428","EFO_0003767","EFO_0005251","EFO_0006834","EFO_1001905","EFO_0004992","MONDO_0007254","EFO_0009267","EFO_1000637","EFO_0002950","MONDO_0001056","EFO_1000783","MONDO_0002050","EFO_0007202","EFO_0003030","HP_0002094","EFO_0009508","EFO_0000685","EFO_0004210","MONDO_0021204","EFO_0001645","HP_0002571","HP_0011110","EFO_0000232","EFO_1001267","EFO_0001073","EFO_0003843","HP_0002315","EFO_0000311","EFO_0000713","EFO_0010282","EFO_0004273","EFO_0001421","EFO_1001373","EFO_0005611","MONDO_0043510","EFO_0003918"],"count":69},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1968 and has 3 approved and 23 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL64545","canonicalSmiles":"CN(C)CCOC(=O)COc1ccc(Cl)cc1","inchiKey":"XZTYGFHCIAKPGJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MECLOFENOXATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Centrophenoxine","Clophenoxate","Meclofenoxate","Meclofenoxate hydrochloride"],"crossReferences":{"PubChem":["11110999","11111000","50110990","90341454"],"drugbank":["DB13758"],"chEBI":["6712"]},"childChemblIds":["CHEMBL1256131"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL66115","canonicalSmiles":"Nc1ccn([C@H]2C[C@H](O)[C@@H](CO)O2)c(=O)n1","inchiKey":"CKTSBUTUHBMZGZ-SHYZEUOFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEOXYCYTIDINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2'-Deoxycytidine","Deoxycytidine"],"crossReferences":{"PubChem":["26754278"],"Wikipedia":["Deoxycytidine"],"drugbank":["DB02594"],"chEBI":["15698"]},"childChemblIds":["CHEMBL1356971","CHEMBL1873101"],"count":4,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL73148","canonicalSmiles":"NC(=O)N(O)CCC#C[C@@H]1CC[C@@H](COc2ccc(F)cc2)O1","inchiKey":"YANONWCPCKIWEC-CABCVRRESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CMI-977","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CMI-977"],"crossReferences":{"drugbank":["DB05431"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL746","canonicalSmiles":"CCCc1c2oc(C(=O)O)cc(=O)c2cc2c(=O)cc(C(=O)O)n(CC)c12","inchiKey":"RQTOOFIXOKYGAN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NEDOCROMIL","yearOfFirstApproval":1992,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["FPL 59002","FPL-59002","Nedocromil"],"crossReferences":{"DailyMed":["nedocromil%20sodium"],"PubChem":["144206699","170464978"],"Wikipedia":["Nedocromil"],"drugbank":["DB00716"],"chEBI":["7492"]},"childChemblIds":["CHEMBL2105133","CHEMBL915"],"count":4,"approvedIndications":["HP_0006536","EFO_0005751","HP_0001742"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1992 and has 3 approved and 1 investigational indication."}
{"id":"CHEMBL77961","canonicalSmiles":"CC1(C)CCC(C)(C)c2cc(/C(=N\\O)c3ccc4cc(C(=O)O)ccc4c3)ccc21","inchiKey":"RNZIUDLOJHVHLZ-VYIQYICTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL77961","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02258"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL80257","canonicalSmiles":"O=C(O)[C@H]1CCCN1","inchiKey":"ONIBWKKTOPOVIA-SCSAIBSYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"D-PROLINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["D-Proline","Pyrrolidine-2-Carboxylic Acid"],"crossReferences":{"PubChem":["26756694"],"drugbank":["DB02853"],"chEBI":["16313"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL9","canonicalSmiles":"CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21","inchiKey":"OGJPXUAPXNRGGI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"NORFLOXACIN","yearOfFirstApproval":1986,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Baccidal","Chibroxin","Noroxin","Quinabic","Utinor"],"synonyms":["MK-366","Norfloxacin","Noroxin"],"crossReferences":{"PubChem":["11112831","124882669","144204233","144206991","170464769","174007429","26746929","855614"],"Wikipedia":["Norfloxacin"],"drugbank":["DB01059"],"chEBI":["100246"]},"count":8,"approvedIndications":["EFO_0000771","EFO_1001888"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1986 and is indicated for eye infection and bacterial disease and has 6 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL918","canonicalSmiles":"NC(=O)NC(=O)Cc1ccccc1","inchiKey":"XPFRXWCVYUEORT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENACEMIDE","yearOfFirstApproval":1951,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Phenurone"],"synonyms":["Phenacemide"],"crossReferences":{"PubChem":["144204878","170465322","26748194"],"Wikipedia":["Phenacemide"],"drugbank":["DB01121"],"chEBI":["8049"]},"count":1,"approvedIndications":["EFO_0000474"],"linkedTargets":{"rows":["ENSG00000185313","ENSG00000196876","ENSG00000183873","ENSG00000136546","ENSG00000144285","ENSG00000169432","ENSG00000168356","ENSG00000007314","ENSG00000136531","ENSG00000153253"],"count":10},"linkedDiseases":{"rows":["EFO_0000474"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1951 and is indicated for epilepsy."}
{"id":"CHEMBL92608","canonicalSmiles":"CCOC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(=O)NO)CC(C)C","inchiKey":"XKRONJXEXGFBRZ-ZNMIVQPWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"Ro-31-4724","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ro-31-4724"],"crossReferences":{"drugbank":["DB08482"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL968","canonicalSmiles":"CCN(CC)CCN1C(=O)CN=C(c2ccccc2F)c2cc(Cl)ccc21","inchiKey":"SAADBVWGJQAEFS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"FLURAZEPAM","yearOfFirstApproval":1970,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Dalmane","Flurazepam"],"crossReferences":{"DailyMed":["flurazepam%20hydrochloride"],"PubChem":["144205754","170465018","26757995"],"Wikipedia":["Flurazepam"],"drugbank":["DB00690"]},"childChemblIds":["CHEMBL3989724"],"count":5,"linkedTargets":{"rows":["ENSG00000182256","ENSG00000022355","ENSG00000011677","ENSG00000163285","ENSG00000151834","ENSG00000113327","ENSG00000186297"],"count":7},"linkedDiseases":{"rows":["MONDO_0002050","HP_0000726","EFO_0005230","EFO_0004698","EFO_0000692"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1970 and has 5 investigational indications. This drug has a black box warning from the FDA."}
